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An acute bout of unaccustomed eccentric exercise causes prolonged strength loss 
and delayed onset muscle soreness (DOMS) for several days.  Chronic dietary 
supplementation with polyphenols, from pomegranates, has been shown to accelerate 
recovery following eccentric exercise, but the optimal dose is unknown.  The purpose of 
this study was to determine the effect of dietary supplementation with different doses of 
pomegranate juice concentrate (PJC) on muscular strength, power, and soreness 
throughout a 96-hour time period following an acute bout of eccentric exercise.  Healthy 
recreationally active males (n=45) were assigned to one of three treatment groups: Once-
daily PJC (1x), twice-daily PJC (2x), or placebo (PLA) supplementation over a period of 
eight days.  A 1x dose of PJC provided approximately 650 mg GAE.  On day four of each 
treatment, subjects performed downhill running intervals (-10% grade) over a 40-minute 
period followed by 40 repetitions of eccentric elbow flexion at 100% of concentric 1-RM.  
Muscle soreness of arms and legs, maximal isometric strength of the elbow flexors (EF) 
 v 
 
and knee extensors (KE), vertical jump height (VJheight) maximal cycling power (Pmax), 
and 10-meter sprint velocity (V10m) were assessed pre-exercise and 2, 24, 48, 72, 96 hours 
post-exercise.  Additionally, maximal instantaneous power (IPmax), maximal velocity 
(Vmax), maximal torque (Tmax), and torque at 0° (T0) were assessed on the inertial load 
power cycle pre-exercise and 24, 48, 72, 96 hours post-exercise. Throughout the 96-hours 
post-exercise, isometric EF strength was significantly higher in 1x and 2x groups as 
compared to PLA (main treatment effect, 83.6 ± 2.7% vs. 85.6 ± 1.9% vs. 78.4 ± 1.8%, 
respectively; p < 0.001).  Isometric KE strength was significantly higher in 1x and 2x 
groups as compared to PLA (main treatment effect, 93.9 ± 1.5% vs. 91.6 ± 1.5% vs. 87.1 
± 1.8%, respectively; p < 0.001).  Both VJ and V10m were significantly higher in 1x 
compared to PLA (main treatment effect, 99.9 ± 0.9% vs. 98.0 ± 1.0%, respectively, p = 
0.037; 100.0 ± 0.8% vs. 97.8 ± 0.7%, respectively, p = 0.003).  Muscle soreness and Pmax, 
were similar at all time points between groups.  We conclude that dietary 
supplementation with 1x or 2x PJC results in higher isometric strength values compared 
to placebo for EF and KE muscles during the 96-hour period after an acute bout of 
eccentric exercise. 
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When an individual performs a bout of exercise, specifically eccentric biased 
exercise, it may result in muscle damage that causes a prolonged strength loss that will 
negatively affect athletic performance [1].   Amidst strength loss, other notable symptoms 
of eccentric induced muscle damage are decreases in range of motion, as well as, 
swelling and delayed soreness of the muscle exercised [2].  This condition following 
eccentric exercise is called delayed onset muscle soreness (DOMS).  In the days 
following exercise, DOMS occurs in individuals who are not accustomed to performing 
exercise with a heavy eccentric component.  Symptoms of DOMS peak 24-48 hours 
following exercise [3].  After 24-48 hours recovery of strength and soreness begin to 
return to baseline values, however this may take 1-2 weeks, and in rare cases up to four 
weeks [4].   
It is believed that during a single eccentric contraction, damage occurs due to 
overstretching or “popping” of weaker sarcomeres.  As the muscle fibers enter a region of 
instability in the length-tension curve, there is greater stretch on individual sarcomeres.  
Stronger sarcomeres contract and are able to resist this stretch, while weaker sarcomeres 
cannot and are forced to relax.  Relaxation of weaker sarcomeres causes them become 
overstretched.  One individual eccentric contraction causes minimal damage, however as 
a higher volume of eccentric contractions is performed, the greater the amount of 
overstretching occurs.  Widespread areas of overstretched sarcomeres cause structural 
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disruption of the muscle fiber resulting in damage to the tissue [5-8].  Damage to the 
muscle fiber allows for increased accumulation of intracellular calcium.  This alteration 
in the muscle fibers ability to maintain normal calcium homeostasis results in reduced 
maximal calcium activated force, reduced titanic calcium, reduced calcium sensitivity, 
elevated resting calcium, and most notably excitation contraction (EC) coupling failure 
[9].  All of these factors result in the severe decrease in strength that is immediately 
associated with eccentric exercise. 
In the hours and days following the initial injury to the muscle fiber, a secondary 
injury occurs that is caused by the summation of oxidative stress [10-12], inflammation 
[13-19].  Phagocytosis of necrotic tissue is a necessary task, however it may be 
detrimental, as the release of reactive oxygen species (ROS) may damage more tissue.  If 
these signaling cascades can be attenuated by either a reduction of oxidative stress and/or 
inflammation, the extent of secondary damage may be lessened and recovery from 
eccentric exercise may be accelerated.   
Dietary supplementation with polyphenols has been effective in improving 
recovery following eccentric exercise [20-30].  The pomegranate fruit, which contains a 
high concentration of polyphenols, has many anti-inflammatory and anti-oxidative 
properties[31].  Previous studies have demonstrated a positive effect in both trained and 
untrained individuals supplementing with 1300 Gallic Acid Equivalents (GAE) per day 
of pomegranate fruit extract prior to and following eccentric exercise [29, 30].  No study 
has been completed to demonstrate if a dose response exists with dietary supplementation 
of pomegranate polyphenols.  Also, no study has been completed testing if the rate of 
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recovery following downhill running would be improved when supplementing the diet 
with pomegranate polyphenols.  We intend to study the effects of differing doses of 
dietary supplementation of pomegranate juice concentrate (PJC) on recovery of strength 




REVIEW OF LITERATURE 
ECCENTRIC EXERCISE 
An eccentric exercise can be described as any exercise in which the muscle resists 
lengthening.  During an eccentric contraction the elongation of the muscle occurs while 
tension is maintained in an effort to decelerate the opposing force.  When an individual 
performs unaccustomed eccentric exercise muscle damage occurs, a demonstrated by 
prolonged strength loss and muscle soreness.  Modes of exercise that result in this type of 
damage are eccentric contractions of isolated muscle groups (i.e. elbow flexors, knee 
extensors, etc.) [1, 8, 10, 13, 16, 17, 21, 27, 32-44] and downhill running [18, 19, 45-57].  
Both exercise types are well studied and effective, repeatable methods to elicit eccentric 
exercise induced muscle damage.   
Eccentric contractions are able to produce greater force than isometric or 
concentric contractions, but the effect they have on the muscle is somewhat deceptive 
[58].  Fatigue during concentric contractions is due to metabolic fatigue and is 
distinguishable by the burning feeling in exercising muscles.  This is not the case when 
performing eccentric exercise [3].  Eccentric exercise is not nearly as metabolically 
stressful as concentric exercise, however during high force eccentric exercise there is 
damage to the muscles that performed the exercise [40, 59].  This type of damage does 
not occur during concentric exercise, however it does contribute to fatigue, as the force 
generating capacity of the muscle is diminished due to loss in structural integrity of the 
muscle.  An individual who has performed eccentric exercise may not feel as though they 
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have worked hard, however strength loss is similar to that following concentric 
contractions of the same muscle group [40].   
Although during eccentric exercise, the force of muscle contraction can be greater 
than during isometric or concentric exercise [60], muscle damage can occur even at 
submaximal intensities assuming the volume is high enough.  This is demonstrated 
during downhill running. Downhill running requires lower oxygen consumption than 
uphill or flat level running [49, 56], soreness occurs almost exclusively following 
downhill running, aside from running of extreme distances (i.e. marathon) [20, 23].  
Methods of assessing muscle damage for downhill running are similar to markers seen 
following maximal eccentric contractions, however time course and magnitude differ [4].   
Difference in time course and magnitude of damage may be due to force of 
contractions being lessened in downhill running, the muscle damage achieved during 
maximal eccentric contractions is isolated to single muscles (i.e. elbow flexors: biceps 
brachii and brachialis muscles or in the case of knee extensors: quadricep muscles) as 
opposed to downhill running which requires a large range of muscles of the lower body 
(i.e. quadricep, hamstring, glute, and lower leg plantar flexor muscles).   
Individuals performing downhill running to elicit muscle damage typically run at 
decline of 5-15%, speed corresponding to 60-80% of estimated VO2 peak velocity 
attained on a flat surface, and for duration of 20-60 minutes.  Maximal isometric strength 
of the knee extensors is a primary method used to measure decreases in force output 
following downhill running [18, 47, 48, 50, 51].  Typically, the initial decrease in 
isometric strength from downhill running is between 10-25% of pre-exercise values and 
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increase linearly until complete recovery at 5-7 days post-exercise [47, 48].  Aside from 
decreased maximal isometric strength, both running economy [45, 47, 48] and glucose 
tolerance [52] are negatively affected following downhill running.   
Another mode of exercise that can be performed to induce eccentric damage is by 
having an individual perform eccentric contractions with an isolated muscle group.  
Typically, muscles of the elbow flexors or knee extensors are used for this type of study 
design.  An individual may complete eccentric contractions isotonically or isokinetically.  
Isokinetic eccentric contractions allow the researchers to quantify work completed, 
however a limitation of this device is that the individual must resist maximally, which is 
somewhat subjective, as the individual can “fake it”.  Isotonic eccentric contractions 
allow the individual to perform eccentric contractions using a weight, usually a certain 
percentage of their 1-RM [30].  Strength loss for maximal isometric strength following 
eccentric contractions of a single muscle or muscle group typically range from 30-60% 
lower than maximal values.  A greater decrease may be due to the fact that greater force 
of contractions are usually associated with this type of eccentric exercise and/or the 
isometric strength testing is performed using the same movement and thus same muscles 
used to perform eccentric exercise.  This may give a more specific indicator of muscle 
damage sustained, unlike when testing isometric strength following downhill running, as 
downhill running affects a wider range of muscles impossible to test simultaneously.   
DELAYED ONSET MUSCLE SORENESS 
Exercise induced muscle damage occurs primarily, but not exclusively, during 
exercise that is both unaccustomed to the individual and contains high volume or force 
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eccentric contractions [40, 59].  Exercise of this type includes repeated eccentric 
contractions of the elbow flexors or knee extensors [1] and downhill running [57].  
Immediately following exercise, strength is reduced.  This strength loss is similar to what 
is observed following concentric contractions [40].  However, unlike strength recovery 
following concentric contractions, which takes 1-2 hours, strength recovery after 
eccentric exercise is negligible during that time period [4].  Amidst prolonged strength 
loss, the muscle group that performed eccentric exercise may demonstrate a reduced 
range of motion and slight muscular soreness and swelling, as well.  In the days 
following eccentric exercise, muscle damage increases [61], strength remains attenuated, 
and swelling may develop in the body part exercised [53].  However, the most notable 
consequence occurs in the days following novel eccentric exercise.   
Although an individual may be slightly sore in the hours following eccentric 
exercise, soreness tends to drastically peak 24-48 hours post-exercise [3].  This delayed 
occurrence of soreness is Delayed Onset Muscle Soreness (DOMS).  While DOMS 
typically subsides within one week., strength loss and swelling may linger for up to one 
month following a bout of unaccustomed eccentric exercise [4].  Because the exact 
causative mechanisms that cause DOMS are still relatively unknown, this review will 
briefly describe hypothetical events leading to this condition and therapeutic remedies 
that have been aimed at speeding recovery.   
The first scientific publishing that recognized a DOMS-like effect of soreness was 
by Theodore Hough at the turn of the 20th century   Hough stated that “when an untrained 
muscle makes a series of contractions against a strong spring, a soreness frequently 
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results which cannot be regarded as a phenomenon of pure fatigue [62].”  Although this 
recognition of DOMS was observed as a confounding variable in that study, the 
following year Hough published a study delving into possible mechanisms and modes of 
exercise that cause this atypical soreness.  In the follow up study the soreness was simply 
referred to as “the second kind of soreness.”  Hough postulated this soreness was caused 
by “some sort of rupture within the muscle” that occurred only in untrained muscle.  
Although relatively correct, he was unable to determine mechanisms that cause delayed 
soreness, as some study participants developed DOMS, while other did not.  Therefore he 
suggested that in future studies any subjects that reported “the second kind of soreness”, 
simply be discarded [63].  These studies by Hough were the first to identify what would 
later be referred to as DOMS, however the mechanisms causing it lay unknown and 
relatively unstudied for over half a century.  
INITIAL INJURY 
It was in the 1950’s it was well known that eccentric contractions produced more 
force and required less energy than either isometric or concentric contractions [58].  
However, it was in 1956, that Erling Asmussen who discovered that performing eccentric 
contractions is what causes DOMS [2].  Prior to and following this finding, many theories 
existed on what occurs within the muscle during and/or following eccentric contractions 
that cause DOMS.  It was in 1981 that Friden and colleagues shed some light on this 
topic by taking muscle biopsies prior to and 48 hours following eccentric exercise. 
Biopsies taken prior to exercise displayed normal muscle fiber arrangement, however 
biopsies taken 48 hours after exercise displayed damage as evidenced by disruption and 
 9 
disorganization of sarcomeres [61].  The damage to the muscle fibers seemed to originate 
from the Z-band, indicating the eccentric exercise may induce damage due to a structural 
weakness in the Z-discs.  This study was the first to show extensive damage to the muscle 
after eccentric exercise, however, since no muscle biopsies were taken immediately after 
exercise the exact cause of DOMS could not be determined.   
Newham and colleagues analyzed biopsies taken from the vastus lateralis of either 
concentrically or eccentrically exercised legs.  Biopsies were taken prior to, immediately 
after and 24-48 hours after performing 20 minutes of bench stepping exercise.  Subjects 
used one leg to step up concentrically and the other to step down eccentrically, thereby 
following exercise one leg had only exercised concentrically and the opposite leg had 
only exercised eccentrically.  Immediately following and 24-48 hours after exercise, 
negligible damage was present in the leg that performed exercise concentrically.  
However, in the leg that had performed eccentric contractions, damage was present 
immediately after exercise similar to that seen by Friden and colleagues.  It was also 
observed that damage present in muscle biopsies taken 24-48 hours after exercise was 
greater in magnitude than damage assessed immediately following exercise [59].  Thus, it 
was implied that at some point during the 24-48 period of time following eccentric 
exercise the muscle was damaged further.  Another notable finding in this study was that 
concentric exercise does not lead to DOMS, as no damage was sustained during or after 
exercise. 
The results of these studies on exercise induced muscle damage led to many 
theories on what exactly happens during and after eccentric exercise to cause damage and 
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DOMS.  The predominately accepted theory is that initial damage occurred is due to the 
overstretching or “popping” of weaker sarcomeres.  During an eccentric contraction, as 
the muscle fibers enter a region of instability in the length-tension curve, there is greater 
stretch on individual sarcomeres.  Stronger sarcomeres contract to resist this stretch, 
while weaker sarcomeres cannot.  As weaker sarcomeres relax, they become 
overstretched.  One individual eccentric contraction may cause this overstretching of 
weaker sarcomeres, causing minimal damage, however as more eccentric contractions are 
performed, more sarcomeres become overstretched.  Widespread areas of overstretched 
sarcomeres causes massive disruption of the muscle fiber structure and results in damage 
to the muscle fibers [5-8].  The acceptance of this theory is not without its doubters, as 
the cause of initial strength loss is still undetermined as there are other effects of 
eccentric exercise that occur that are able to partially explain strength loss.   
Increased accumulation of intracellular calcium occurs after eccentric exercise 
and affects excitation contraction (EC) coupling; causing significant strength loss [9].  
This alteration in the muscle’s fibers ability to maintain normal calcium homeostasis 
results in reduced maximal calcium activated force, reduced tetanic calcium, reduced 
calcium sensitivity and raised resting calcium [9].  Although this alteration in calcium 
homeostasis may be caused by disruption and damage to the muscle fibers, it has been 
shown that when eccentrically contracted muscle is exposed to caffeine, most of the force 
decrement is abolished [9, 64].  This indicates that alterations in calcium homeostasis do 
affect strength loss after exercise.  This also indicates that, although the eccentrically 
contracted muscle is damaged, damage is not what plays a major part in initial strength 
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loss.  If damage and disorganization played a major part in strength loss, it would not be 
able to be recovered by caffeine exposure.  Thus, there is a strong argument for the case 
of EC coupling failure via altered calcium homeostasis as the factor contributing most to 
post-exercise decrease in strength, although arguments continue for proponents of both 
theories.   The exact mechanism causing the initial decrease in strength following 
eccentric exercise is still unknown and most likely impossible to find out, but it is nearly 
indisputable that the initial strength loss is resultant from either damage and/or EC 
coupling failure of the muscle. 
SECONDARY INJURY 
In the hours and days following the initial injury to the muscle fiber a secondary 
injury takes occurs.  Immediately following exercise, whether eccentrically or 
concentrically biased, muscle begins to recover.  However, it has been shown that 6-12 
hours following unaccustomed eccentric exercise, a secondary injury occurs resulting in 
an additional drop in strength and more muscle damage [13, 38].  The secondary injury 
that occurs is caused by the summation of oxidative stress [10-12], inflammation [13-19] 
and possibly by activation of intracellular calcium dependent proteases [44, 65] at the site 
of the initial injury.  Immediately following exercise, an initial wave of white blood cells, 
consistent of neutrophils and macrophages, accumulate at the site of injury, followed by a 
delayed wave of macrophages 24-48 hours later [13, 14, 17, 66, 67].  Although, 
neutrophils and macrophages are necessary for recovery from eccentric exercise induced 
muscle damage, as they phagocytize and regenerate the damaged tissue [14].  A 
potentially detrimental effect of phagocytic metabolism is the release of reactive oxygen 
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species (ROS) that may actually damage more tissue and kill the leukocyte.  It has been 
shown that macrophages do not contribute to muscle injury, and are generally associated 
with regeneration [66, 67].  However, it is neutrophils that have been shown to cause 
injury to muscle tissue [14, 15, 33, 39, 68].  When neutrophils are cultured with skeletal 
muscle myotubes, damage to the tissue increases as the concentration of neutrophils 
increase [68].  Study in rats has shown that when the neutrophil binding site on the 
endothelium is removed, neutrophil accumulation to the site of injury is prevented and 
isometric force is recovered faster [15].  Both of these studies indicate that neutrophils 
play a part in impairment of recovery from muscle damage, however this has been shown 
to not be true in all cases, as some data show that neutrophil infiltration is a necessity for 
recovery [42].    
Following eccentric exercise intracellular calcium is increased in the injured 
muscle fibers.  This activates intracellular calcium dependent proteases, “calpain” [44] 
and “caspases” [65]..  Activated proteases may act as another method of damage to 
muscle following eccentric exercise.  Additionally,  increased ROS, as well as 
intracellular calcium, cause mitochondrial release of cytochrome C as another mechanism 
of these proteolytic proteases [69].  Mitochondrial calcium uptake itself may also result in 
production of ROS [10].  Regardless, excessive ROS production causes further oxidative 
stress and may cause greater membrane damage, increasing membrane permeability.  
Damage to the cell membrane results in increased signaling of inflammatory cells meant 
to regenerate and degrade damaged tissues, however these cells continually release ROS.  
Thus, results in a cycle of repetitive damage that leads to more extensive damage.  If 
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these signaling cascades can be attenuated by either a reduction of oxidative stress and/or 
inflammation, the extent of secondary damage may be lessened and recovery from 
eccentric exercise may be accelerated.   
DIETARY SUPPLEMENTATION 
Dietary supplementation in humans and animals with traditional anti-oxidants 
(vitamin C & E) [32-35, 39, 41, 70] or non-steroidal anti-inflammatory drugs (NSAIDs) 
[36, 37, 43] has been studied as a method aimed at reducing secondary damage following 
eccentric exercise.  It is believed that if oxidative stress and/or inflammation can be 
attenuated DOMS will be mitigated.  However, studies supplementing with anti-oxidants 
and NSAIDs have shown equivocal results, with the general consensus being that they do 
not improve recovery following novel eccentric exercise.  In one study, supplementation 
with vitamin E may have actually increased damage, as observed by increased release of 
creatine kinase, a marker of membrane permeability associated with muscle damage [33].  
NSAIDs are similarly ineffective at improving recovery following eccentric.  However, 
some NSAIDs have been shown to decrease soreness following eccentric exercise [37], 
but have no effect on recovery of strength [36, 37].  Overall, researchers agree that 
dietary supplementation with traditional anti-oxidants and NSAIDs do not aid in recovery 
from eccentric exercise. 
An untraditional type of dietary supplementation is polyphenol supplementation.  
Polyphenol supplementation has been observed to be effective in improving recovery 
following novel eccentric exercise [20-30].  Polyphenols are a class of phytonutrients that 
contain potent anti-oxidant and anti-inflammatory properties that may aid in recovery of 
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muscle damage [31].  When injured human myotubes are exposed to the polyphenolic 
compound curcumin regeneration of muscle tissue occurs at a faster rate [71].  Davis and 
colleagues demonstrated beneficial effects of dietary curcumin supplementation in vivo 
using a mouse model of downhill running.  Mice who were supplemented with curcumin 
had greater regeneration of muscle tissue and recovery of strength following exercise 
[22].  Polyphenols derived from apple peels have been supplemented in rats have also 
shown improved recovery following eccentric exercise, similar to that of Davis and 
colleagues [26].   
The benefits of polyphenol supplementation in vitro and in vivo in rodents also 
translates to humans as an effective means to improve recovery following eccentric 
exercise [20, 21, 23, 25, 28-30].  Multiple studies providing tart cherry juice have were 
effective in decreasing muscle soreness and/or improving strength recovery following 
marathon running [23, 24] or high force eccentric contractions [20, 21].  Additionally, 
tart juice has also been shown to decrease oxidative stress following an ischemia 
reperfusion challenge [28], thereby demonstrating its value in suppressing ROS stress.  
Pomegranates supplementation improves recovery from eccentric exercise in humans [29, 
30].  The pomegranate fruit itself contain a high concentration of polyphenols among 
polyphenolic compounds [31].  The phytonutrients that account for the majority of the 
polyphenols found in pomegranates are ellagitannins, punicalagins and anthocyannins.  
Among other commonly used polyphenol containing beverages, pomegranate juice has 
been shown to have the highest content of polyphenols and anti-oxidant capacity [72].  
Although anti-oxidant and anti-inflammatory supplementation has yielded equivocal 
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results on recovery from eccentric exercise, it is possible that the unique balance 
phytonutrients found in these polyphenol rich compounds may aid in recovery from 
eccentric exercise in combination. 
When specifically focusing on pomegranate supplementation, Trombold and 
colleagues demonstrated that supplementation of 1300 mg Gallic Acid Equivalents 
(GAE) per day in untrained individuals accelerates isometric elbow flexor strength 
recovery 2-3 days following maximal eccentric contractions of the elbow flexors [29].  A 
follow up study in resistance trained individuals demonstrated an overall treatment effect 
of 1300 mg GAE/day of dietary pomegranate supplementation in recovery of isometric 
elbow flexor strength following maximal eccentric contractions of the elbow flexors [30]. 
The dose used in these studies may be greater than what is commercially available.  To 
the best of our knowledge, no study has been conducted to investigate if a dose response 






Forty-five healthy, non-smoking, recreationally active males (age: 22.3 ± 4 years, weight: 
73.8 ± 11.5 kg, height: 174.9 ± 6.2 cm) recruited from The University of Texas at Austin 
community participated in this study.  The experimental protocol was approved by The 
University of Texas at Austin Institutional Review Board.  All subjects provided written 
informed consent to participate in the experimental protocol and had no history of injury 
to the ankle, knee, hip, wrist, elbow, or shoulder within the last two years and were not 
taking part in any type of physical therapy.  Subjects were disqualified if they had 
participated in any structured resistance training or running program of any type over the 
previous six months.  Subjects were instructed to limit any strenuous activity throughout 
the experimental protocol.  All anti-inflammatory and/or anti-oxidant supplements were 
discontinued and prohibited during the entire experimental protocol.  Other criteria for 
inclusion were: no history of hypertension, kidney dysfunction, active weight loss > 5 kg. 
in the prior 3 months, angiotensin converting enzyme (ACE) inhibitor, lipid-lowering, 
selective serotonin reuptake inhibitor (SSRI) or anti-inflammatory steroid medication use.   
 
DESIGN 
This study was a double-blind, counter-balanced, placebo-controlled experiment with one 
testing period lasting eight days.  Subjects were assigned to one of three supplementation 
groups.  During the eight-day supplementation protocol, the bout of exercise used to elicit 
DOMS was performed on the fourth day of supplementation.  Measures of recovery were 
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made throughout the next four days.  All subject performed modalities of eccentric 
exercise in the same order, with downhill running preceding eccentric contractions of the 
elbow flexors.   
 
Soreness and performance measurements were collected on Day 4 at pre-exercise (PRE), 
2 hours (2h; Day 4), 24 hours (24h; Day 5), 48 hours (48h; Day 6), 72 hours (72h; Day 
7), and 96 hours post-exercise (96h; Day 8).  Each subject reported to the human 
performance laboratory at the same time of day for all subsequent testing days.  
Additionally, a dietary recall was used to ensure that all subjects replicated the same diet 
prior to reporting to the laboratory.   
 
SUPPLEMENTATION 
Supplementation of pomegranate juice concentrate (PJC) or placebo (PLA) were 
consumed each morning and evening, 12 hours apart, starting on Day 1 of the 
experimental protocol following the final familiarization session.  PJC and PLA drinks 
were provided by POM Wonderful Inc., LLP (Los Angeles, CA).  Subjects were assigned 
to one of three groups:  Once-daily (1x), twice-daily PJC (2x), or placebo (PLA) 
supplementation.  During the 1x treatment, subjects supplemented with PJC in the 
morning and placebo in the evening.   
 
Products were provided to subjects in 500 mL bottles.  Each subject received two bottles 
of supplementation, labeled A.M. and P.M., to be taken in the morning and evening, 
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respectively.   Subjects were instructed to dilute one ounce of supplementation in 
approximately eight ounces of water.  Each 16 oz. bottle of PJC contained 650 mg/oz. 
Gallic Acid Equivalents (GAE), while PLA contained 0 mg GAE.  A one-ounce serving 
of both PJC and PLA contained 24 grams of carbohydrate per ounce as maltodextrin, 
sucralose, coloring, and flavoring. 
Eccentric Exercise Protocol 
Eccentric exercise consisted of downhill running intervals and bilateral isotonic eccentric 
contractions of the elbow flexors.  On the morning of Day 4 of the experimental protocol, 
subjects performed the eccentric exercise bout approximately ten minutes following the 
pre-exercise soreness and performance measures.  All subject performed downhill 
running prior to eccentric contractions of the elbow flexors. 
DOWNHILL RUNNING 
Downhill running consisted of 10 sets of running down the ramps of Darrell K. Royal – 
Texas Memorial Stadium.  The ramps of the stadium contain 10 flights of ramps that are 
140 feet in length and decline at a grade of -10%.  All subjects started at the 10th floor and 
ran at a similar pace, 8 mph (2 min/set), set and paced by a member of the research team 
until they arrived at the ground floor.  Following each set, subjects took the elevator back 
to the 10th floor to perform the subsequent set.  The time taken from the end of each set to 
the beginning of the next was considered the rest and was approximately 2-2.5 minutes in 
duration per set.  Total exercise time was approximately 45-50 minutes, consisting of 20 
minutes of downhill running and 25-30 minutes of rest.  In an attempt to ensure equal 
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response between each legs, two sets of ramps were used in alternating fashion, as one 
ramp descended in a clockwise pattern and the other in a counter-clockwise pattern.  
Therefore, no leg would be favored or affected more by the direction of turns between 
flights.   Throughout the downhill running protocol subjects were provided water and 
drank ad libitum during the rest periods.   
ISOTONIC ECCENTRIC CONTRACTIONS 
Approximately 10 minutes following the final set of downhill running, subjects began the 
eccentric contractions of the elbow flexors portion of the exercise protocol.  Subjects 
performed 40 repetitions of bilateral isotonic eccentric contractions of the elbow flexors 
at a load equal to 100% concentric one-repetition maximum (1-RM) using an EZ curl 
barbell.   Subjects were seated on a preacher curl apparatus with the posterior side of the 
upper arm flat against the cushion of preacher curl apparatus.  On the subjects ready, the 
tester would place the barbell in the subject’s hands.  The tester ensured that the subject 
was ready to perform the eccentric contraction by asking “are you ready?”  On the 
tester’s signal, the participant was instructed to lower the barbell eccentrically with 
control from complete elbow flexion to complete elbow extension at the command 
“5,4,3,2,1,0.”  At “0” the subject was at complete elbow extension and maintained 
tension until the tester took the barbell from the subject.  This was repeated for 40 
repetitions, with approximately 20-30 seconds rest between each repetition.  If at any 
point the subject was unable to maintain control of the eccentric contraction or lost 
muscle tension during the five-second count, a five-minute rest was given and the 
protocol was then continued until a total of 40 repetitions were accumulated. 
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Performance Measurements 
Performance measurements were done in the similar postprandial state and same order 
for every subject preceded by measurements of local muscle soreness.  Ordering of 
performance measurements was:  (1) Isometric knee extensor (KE) strength, (2) isometric 
elbow flexor (EF) strength, (3) inertial load maximal cycling power (Pmax), (4) vertical 
jump (VJheight), and (5) 10-meter sprint velocity (V10m)  
ISOMETRIC KNEE EXTENSOR STRENGTH 
Isometric KE strength was measured bilaterally using a modified knee extension 
apparatus.  Each subject was strapped into the knee extension device at the waist and 
shoulders.  Strength was recorded using a load cell (LC101-500, Omega Engineering, 
Stamford, CT) secured to the base of the apparatus using a galvanized steel cable and 
secured to the subject’s lower legs by padded ankle straps.  The subjects performed three 
trials, at 65° of knee flexion, with 120 seconds rest in between each trial.  Isometric KE 
strength was reported as the peak value (kg) attained in each trial.  This measurement was 
performed at PRE, 2h, 24h, 48h, 72h, and 96h post-exercise.   
ISOMETRIC ELBOW FLEXOR STRENGTH 
Isometric EF strength was measured bilaterally while seated on a modified preacher curl 
apparatus.  Strength was recorded using a load cell (LC101-500, Omega Engineering, 
Stamford, CT) secured to the base of the apparatus using a galvanized steel cable and 
connected to a curl bar the subjects held in their hands.  The subjects performed three 
trials, at 135° of elbow extension, with 120 seconds rest in between each trial.  Isometric 
 21 
EF strength was reported as the peak value (kg) attained in each trial.  This measurement 
was performed at PRE, 2h, 24h, 48h, 72h, and 96h post-exercise.   
INERTIAL LOAD MAXIMAL CYCLING POWER 
Pmax, maximal instantaneous power (IPmax), maximal velocity (Vmax), maximal torque 
(Tmax) and torque at 0° (T0) were determined using an inertial load cycle ergometer as 
described previously [73].  This testing procedure has been proven valid, reliable, and 
safe through repetitive use in our laboratory.  Each subject performed four maximal 
efforts with 60 seconds of rest provided between each trial.  Pmax, IPmax, Vmax, Tmax and Ti 
were determined from the average of the top two values for Pmax.  Pmax was defined as the 
highest power attained averaged over one revolution, while IPmax was defined as the 
highest power attained at any degree of any revolution.  Tmax was defined as the highest 
torque attained averaged over one revolution, while T0 was defined as the torque at an 
angular velocity of 0° per second.  Vmax was defined as the highest angular velocity 
attained.  This measurement was performed at PRE, 2h, 24h, 48h, 72h, and 96h post-
exercise.   However, due to constraints of the software used for analysis, values for IPmax, 
Vmax, Tmax and T0 were only obtained at PRE, 24, 48h, 72h, and 96h post-exercise.  In 
some cases the average of the top two values for Pmax wasn’t available to obtain values for 
IPmax, Vmax, Tmax and T0.  Under these circumstances values for IPmax, Vmax, Tmax and T0 
were assessed from the highest value for Pmax.   
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VERTICAL JUMP HEIGHT 
VJheight was determined using a Vertec jump training apparatus (Gill Athletics, 
Champaign, IL).  Prior to the first attempt subjects were instructed to stand directly under 
the Vertec blades and reach the dominant hand upward, perpendicular to the floor and 
parallel to the Vertec apparatus.  The highest blade touched was recorded as standing 
reach height.  Following measurement of reach height, each subject was instructed to 
stand directly under the Vertec blades in the same location as the standing reach height 
measurement and perform a countermovement jump with an arm swing, both at self 
selected speed. At the highest portion of the jump the subject reached with the dominant 
hand and tapped the highest blade.  The difference in vertical distance between standing 
reach height and the highest blade touched (jump height) was recorded as VJheight.  
Following each jump the blades of the Vertec below the previous attempt were moved to 
encourage the participant to reach higher on the subsequent attempt.  Each subject 
performed a minimum of three attempts, with 30 seconds of seated rest provided prior to 
each attempt.  An attempt was defined as a countermovement jump with proper form.  If 
on the third attempt, the jump height increased, the subject rested and performed another 
attempt.  This continued until the subject was unable to increase jump height.  The 
highest value attained, to the nearest half-inch was recorded as VJheight and later converted 
to cm.  This measurement was performed at PRE, 2h, 24h, 48h, 72h, and 96h post-
exercise.   
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10-METER SPRINT VELOCITY 
V10m was determined using an infrared laser-timing device (Brower Timing Systems, 
Draper, UT).  Each subject was instructed to stand in a sprinter’s stance with the front 
foot on a touch sensitive mat that started on release.  On the subject’s go they sprinted a 
distance of 10 meters as fast as they could.  Each subject performed two trials with 
approximately 30 seconds rest provided between trials.  The fastest time to sprint 10 
meters was recorded and rounded to the nearest one-hundredth.  This measurement was 
performed at PRE, 2h, 24h, 48h, 72h, and 96h post-exercise.   
Soreness Measurements 
Soreness of elbow flexor and knee extensor muscles was determined by having subjects 
rate the degree of local muscle soreness from 0 to 10 using a visual analog scale (VAS), 
with 0 described as “no soreness” and 10 described as “unbearable soreness” (Figure 2).  
This rating was obtained before all performance measurements and was assessed by 
performing bilateral isometric elbow extension, unloaded concentric elbow flexion, 
unloaded squat and unloaded concentric knee extension.   
ISOMETRIC ELBOW EXTENSION SORENESS 
Isometric elbow extension soreness was performed bilaterally on the same modified 
preacher curl apparatus used for isometric EF strength tests.  With the subject seated, a 
member of the research team would instruct the subject to extend the elbow to complete 
extension.  Once in the position of complete elbow extension perceived soreness 
measurement was recorded by having the subject rate the degree of soreness at complete 
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elbow extension using the VAS.  This test was performed at PRE, and 2h, 24h, 48h, 72h, 
96h post-exercise.   
UNLOADED ELBOW FLEXION SORENESS 
Unloaded elbow flexion soreness was performed bilaterally on the same modified 
preacher curl apparatus used for isometric strength tests of the elbow flexors.  With the 
subject seated, a member of the research team instructed the subject to concentrically 
contract the elbow flexors from complete elbow extension to complete flexion.  
Following movement into complete elbow flexion, perceived soreness was recorded by 
having the subject rate the degree of soreness throughout the entire movement using the 
VAS.  This test was performed at PRE, 2h, 24h, 48h, 72h, and 96h post-exercise.   
UNLOADED SQUAT SORENESS 
Unloaded squat soreness was measured by having the subject perform a squat from 
standing position to a predetermined height and return to a standing position.  Once in the 
subject returned to the standing position perceived soreness was recorded by having the 
subject rate the degree of soreness throughout the entire movement using the VAS.  This 
test was performed at PRE, 2h, 24h, 48h, 72h, and 96h post-exercise.   
ISOMETRIC KNEE EXTENSION SORENESS 
Isometric knee extension soreness was measured bilaterally using the same modified 
knee extension apparatus as used for isometric strength tests of the knee extensors.  Each 
subject was strapped into the knee extension device at the waist and shoulders.  With the 
subject seated, a member of the research team would instruct the subject to extend the 
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knee to complete extension.  Once in the position of complete knee extension perceived 
soreness measurement was recorded by having the subject rate the degree of soreness 
using the VAS.  This test was performed at PRE, 2h, 24h, 48h, 72h, and 96h post-
exercise.   
FAMILIARIZATION 
Prior to the start of the experimental protocol subjects reported to the human performance 
laboratory at The University of Texas at Austin on three occasions to familiarize 
themselves with the testing procedures.  Familiarization trials were required to ensure 
each subject was comfortable and able to perform maximally on all measurements.  Three 
total trials were performed at least 24 hours apart.  The day of the final familiarization 
trial was considered Day 1 of the experimental protocol.  All settings for soreness and 
performance measurement devices were recorded and replicated during ever testing 
session of the experimental protocol.   
1-RM TESTING 
Prior to the performing eccentric contractions of the elbow flexors, each subject’s 1-RM 
was determined.  1-RM was determined by having the subject perform one bilateral 
elbow flexion concentrically using a weight that was approximately 80% of their 
maximal isometric elbow flexor strength.  Weight was increased dependent on the 
participant’s perceived level of difficulty, until failure occurred.  The highest weight able 
to be lifted through the entire range of motion was considered the subject’s 1-RM.   The 
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subject was allowed 60 seconds rest between attempts.  Approximately five minutes 
following the final attempt the subjects began the eccentric exercise protocol.   
STATISTICAL ANALYSIS 
Two-way ANOVA was used for treatment, time, and treatment X time effects for 
performance measurements (% of PRE) and muscle soreness.  The Bonferroni post-hoc 
analysis was applied.  Significance was assessed at alpha level of p < 0.05.  Values were 






There were no significant differences between 1x, 2x or PLA treatment groups for 
subjects’ age (22.1 ± 1.0 vs. 22.5 ± 1.4 vs. 22.2 ± 0.6 y, respectively, p > 0.05), height 
(173.90 ± 1.2 vs. 176.3 ± 1.6 vs. 175.5 ± 1.3 cm, respectively, p > 0.05) or weight (72.1 ± 
2.2 vs. 74.4 ± 3.2 vs. 74.9 ± 3.4 kg, respectively, p > 0.05).   
ECCENTRIC EXERCISE 
All subjects completed both eccentric exercise protocols with downhill running preceding 
eccentric contractions of the elbow flexors in all conditions.  Downhill running speed was 
not significantly different between 1x, 2x, and PLA treatments (7.6 ± 0.03 vs. 7.6 ± 0.1 
vs. 7.7 ± 0.1 mph, respectively; p > 0.05).   Weight used for eccentric contractions of the 
elbow flexors was no different between 1x, 2x, and PLA treatments (31.8 ± 2.1 vs. 30.6 ± 
2.1 vs. 30.6 ± 1.6 kg, respectively; p >0.05).  All subjects completed 40 repetitions of 
eccentric elbow flexion using the weight lifted for concentric 1-RM, therefore there was 
no difference in volume completed between 1x, 2x, and PLA treatment (1272.7 ± 85.1 vs. 
1224.2 ± 82.2 vs. 1224.2 ± 65.1 kg, respectively, p > 0.05).  
Performance Measurements 
Performance measurements were normalized to maximal value measured in 0-hour 
testing session and reported as a percentage of that level (%). 
 28 
ISOMETRIC KNEE EXTENSOR STRENGTH 
Isometric KE strength during the 2- to 96-hour post-exercise period was significantly 
different between 1x, 2x, and PLA treatments (main treatment effect, 93.9 ± 1.5% vs. 
91.6 ± 1.5% vs. 87.1 ± 1.8%, respectively; p < 0.001).  Both 1x and 2x treatments were 
significantly higher than PLA (p < 0.001 and p = 0.004, respectively).  There was no 
significant difference between 1x and 2x treatments (p > 0.05).  There was an overall 
time effect of exercise during the 96-hour testing period in all treatments (p < 0.05).  At 
the 2-hour time point isometric knee extension strength was significantly reduced in 1x, 
2x, and PLA treatments compared with 0-hour time point (88.9 ± 2.3%, 87.4 ± 1.6%, and 
86.7 ± 2.5%, respectively; p < 0.05).  There was no treatment X time effect between 
treatments (p > 0.05) (Figure 7). 
ISOMETRIC ELBOW FLEXOR STRENGTH 
Isometric EF strength during the 2- to 96-hour post-exercise period was significantly 
different between 1x, 2x, and PLA treatments (main treatment effect, 83.6 ± 2.7% vs. 
85.6 ± 1.9% vs. 78.4 ± 1.8%, respectively; p < 0.001).  Both 1x and 2x treatments were 
significantly higher than PLA (p = 0.004 and p < 0.001, respectively).  There was no 
significant difference between 1x and 2x treatments (p > 0.05).  There was an overall 
time effect of exercise during the 96-hour testing period in all treatments (p < 0.001).  At 
2-hour time point isometric elbow flexion strength was significantly reduced in 1x, 2x, 
and PLA treatments compared with 0-hour time point (73.5 ± 2.8%, 76.7 ± 2.1%, and 
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74.9 ± 2.0%, respectively; p < 0.001).  There was no treatment X time effect between 
treatments (p > 0.05) (Figure 8). 
INERTIAL LOAD MAXIMAL CYCLING POWER 
Pmax during the 2- to 96-hour post-exercise period was not significantly different between 
1x, 2x, and PLA treatments (main treatment effect, 96.3 ± 1.2% vs. 95.5 ± 1.2% vs. 94.6 
± 0.7%, respectively; p > 0.05).  There was an overall time effect of exercise during the 
96-hour testing period in 2x and PLA treatments (p < 0.05), while no effect of time was 
present in 1x treatment (p > 0.05) (Figure 9).  IPmax was not significantly different 
between 1x, 2x, and PLA treatment (main treatment effect, 96.9 ± 1.4% vs. 98.6 ± 1.8% 
vs. 98.3 ± 1.7%, respectively; p > 0.05) during the PRE to 96-hour period after exercise 
(Figure 10).  Vmaz was significantly different between 1x, 2x, and PLA treatments (main 
treatment effect, 100.9 ± 1.6% vs. 98.2 ± 1.1% vs. 100.6 ± 1.8%, respectively; p = 0.037) 
during the PRE to 96-hour period after exercise.  The 1x treatment was significantly 
greater than 2x treatment (p = 0.047), but was not different than PLA (p = 1.000), while 
there was a trend for PLA to be greater than 2x (p = 0.084) (Figure 11).  Tmax was not 
significantly different between 1x, 2x, and PLA treatments (main treatment effect, 96.6 ± 
1.8% vs. 98.6 ± 1.7% vs. 95.8 ± 2.2%, respectively; p > 0.05) during the PRE to 96-hour 
period after exercise (Figure 12).  T0 was significantly different between 1x, 2x, and PLA 
treatments (main treatment effect, 117.0 ± 10.8% vs. 100.3 ± 5.2% vs. 101.9 ± 7.3%, 
respectively; p = 0.002) during the PRE to 96-hour period after exercise.  The 1x 
treatment was significantly greater than both 2x and PLA treatment (p = 0.030 and 0.010, 
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respectively) (Figure 13).  There was no effect of time on IPmax, Vmax, Tmax or T0 
throughout the PRE to 96-hour period after exercise (p > 0.05). 
VERTICAL JUMP HEIGHT 
VJheight during the 2- to 96-hour post-exercise period was significantly different between 
1x, 2x, and PLA treatments (main treatment effect, 99.9 ± 0.9% vs. 99.5 ± 1.0% vs. 98.0 
± 1.0%, vs. respectively; p = 0.031).  The 1x treatment was significantly greater than 
PLA (p = 0.037), while the 2x treatment was not significantly different than 1x or PLA 
treatments (p > 0.05).  There was an overall time effect of exercise during the 96-hour 
testing period in 1x and 2x treatments (p < 0.05), while no effect of time was present with 
the PLA treatment (p > 0.05).   There was no treatment X time effect between treatments 
(p > 0.05) (Figure 14). 
10-METER SPRINT VELOCITY 
V10m during the 2- to 96-hour post-exercise period was significantly different between 1x, 
2x, and PLA treatments (main treatment effect, 100.0 ± 0.8% vs. 98.9 ± 0.5% vs. 97.8 ± 
0.7%, respectively; p = 0.019).  The 1x treatment was significantly greater than PLA (p = 
0.003), while the 2x treatment was not significantly different than 1x or PLA treatments 
(p > 0.05).  There was an overall time effect of exercise during the 96-hour testing period 
between all treatments (p = 0.004), however no time effect existed in any individual 




Soreness was reported on a visual analog scale (VAS) of 0-10 (Figure 2).  A value of 0 
indicating “no soreness” and 10 indicating “unbearable soreness.” 
ELBOW EXTENSION SORENESS 
Elbow Extension soreness during the 96-hour post-exercise period was not significantly 
different between 1x, 2x, and PLA treatments (main treatment effect, 2.4 ± 0.4 vs. 2.1 ± 
0.3 vs. 2.1 ± .02, respectively; p > 0.05).  There was an overall time effect of exercise 
during the 96-hour testing period in all treatments (p < 0.001).  There was no treatment X 
time effect between treatments (p > 0.05) (Figure 3). 
ELBOW FLEXION SORENESS 
Elbow flexion soreness during the 96-hour post-exercise period was not significantly 
different between 1x, 2x, and PLA treatments (main treatment effect, 2.6 ± 0.3 vs. 2.4 ± 
0.2 vs. 2.4 ± 0.3, respectively; p > 0.05).  There was an overall time effect of exercise 
during the 96-hour testing period in all treatments (p < 0.001).  There was no treatment X 
time effect between treatments (p > 0.05) (Figure 4). 
UNLOADED SQUAT SORENESS 
Unloaded squat soreness during the 96-hour post-exercise period was not significantly 
different between 1x, 2x and PLA treatments (main treatment effect, 2.0 ± 0.3 vs. 2.0 ± 
0.2 vs. 2.0 ± 0.3, respectively; p > 0.05).  There was an overall time effect of exercise 
during the 96-hour testing period in all treatments (p < 0.001).  There was no treatment X 
time effect between treatments (p > 0.05) (Figure 5). 
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KNEE EXTENSION SORENESS 
Knee extension soreness during the 96-hour post-exercise period was significantly 
different between 1x, 2x, and PLA treatments (main treatment effect, 1.9 ± 0.3 vs. 1.5 ± 
0.3 vs. 1.4 ± 0.3, respectively; p = 0.044).  The 1x treatment group had significantly 
higher values for soreness than the PLA treatment (p = 0.045), while 2x as compared to 
1x or PLA did not differ in treatment effect (p > 0.05).  Two subjects in the 1x treatment 
group rated soreness pre-exercise at values two to three standard deviations higher than 
the mean.  This may have skewed the data.  All subsequent soreness measurements taken 
at this measurement in these individuals were typically higher than the mean response.  
When these subjects are removed there is no difference between groups (p > 0.05).  There 
was an overall time effect of exercise during the 96-hour testing period in all treatments 




The primary finding in this study was that both once daily (1x) and twice daily (2x) 
dietary supplementation with pomegranate juice concentrate (PJC) results in significantly 
higher for isometric knee extensor (KE) and elbow flexor (EF) strength throughout the 
96-hour period following eccentric exercise, as compared to placebo (PLA).  Secondary 
findings indicate that 1x PJC may be a more optimal dose as 10-meter sprint velocity 
(V10m) and vertical jump height (VJheight) throughout the 96-hour period following 
eccentric exercise were higher than those of PLA, while the 2x was not significantly 
different than PLA.  
 
There are a small numbers of studies available that have tested the effects of polyphenol 
supplementation on recovery from eccentric exercise in humans, the majority of which 
are in agreement with our findings [20, 21, 23, 28-30].  To the best of our knowledge 
recovery from downhill running has never been tested with any type of polyphenol 
supplementation.  However, the effect of polyphenol supplementation on recovery from 
running of extreme distances (i.e. marathon) has displayed positive effects [23, 24].   Of 
the studies that have tested the effects of polyphenol supplementation on isometric 
strength recovery following maximal eccentric contractions, two studies had subjects 
supplement with pomegranate polyphenols [21, 29, 30].  Our study supports the findings 
of both of these studies while demonstrating a lower dose may be all that is needed 
Although, one study not shown a beneficial effect for isometric knee extensor strength 
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following eccentric exercise in resistance trained athletes [30].  This study tested 
untrained individuals performing downhill running, therefore limited comparisons can be 
made.   
 
Isometric strength is a direct reflection of muscle damage following eccentric exercise.  
Force loss due to muscle damage may be proportionate to the amount of muscle damage 
attained.  Therefore we can relate and compare the amount of muscle damage attained by 
observing isometric strength loss and recovery between groups [74].  In this study, 
isometric strength loss two hours after exercise was similar between all groups in both 
elbow flexors and knee extensors. As strength loss was no different between groups, the 
extent of damage was no different between groups.  The range of decreases for Isometric 
EF and KE strength for all treatments decreased to values of 73-77% and 87-89%, 
respectively.  A loss of strength of this magnitude at two hours post eccentric exercise is 
in agreement with other studies using similar methods [21, 29, 52, 57].  In the 24 hours 
following exercise, isometric EF and KE strength increased for both 1x and 2x PJC, this 
was not the case for PLA (Figure 8 & 9).  Interestingly, although not significantly 
different, PLA isometric strength decreased over this time period for both isometric EF 
and KE strength.   
 
Immediately following unaccustomed eccentric exercise, neutrophils are signaled and 
accumulate at the site of injury to phagocytose and set the stage for regeneration of the 
damaged tissue [14, 17, 18, 66, 67].  Neutrophils, although necessary for recovery, may 
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actually contribute to secondary damage, as hours after while they phagocytose damaged 
tissue, they release reactive oxygen species (ROS) [14, 15, 68].  Excessive oxidative 
stress caused by ROS may cause secondary damage to muscle tissue that was previously 
being regenerated.  The secondary damage again signals neutrophils to the site of injury, 
[69].  Dietary supplementation of both 1x and 2x PJC may be sufficient to mitigate the 
extent of secondary damage.  
 
Typically 24 hours following eccentric exercise strength remains lower than pre-exercise 
values [4].  Previous studies that test isometric strength multiple times within the first 24 
hours following exercise have shown a bimodal rate of recovery.  Between 6-12 hours 
following the bout, as strength is being recovered there is an additional decrease in 
strength [13, 38].  This second decrease in strength that occurs is due to sum of 
accumulation of inflammatory and oxidative stress at the site of injury. This response has 
only been shown following isolated maximal eccentric contractions of the knee extensors.  
However, there is no reason to discount that its occurrence would not be present 
following eccentric contractions of the elbow flexors or downhill running, as this type of 
inflammatory signaling to the initial site of injury occurs in all individuals performing 
any bout of novel eccentric exercise.   
 
Although there were no differences between treatments observed in inertial load maximal 
cycling power (Pmax), when analyzing the individual factors that determine Pmax, some 
differences exist.  No differences were observed between treatments for maximal 
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instantaneous power (IPmax) or maximal torque (Tmax), however there were effects of 
treatment on maximal velocity (Vmax) and torque at 0° (T0).  Values for 1x PJC were 
higher than 2x PJC for Vmax; T0 was also higher for 1x PJC as compared to 2x and PLA.  
While no difference existed for Vmax between 1x and PLA, PLA trended towards being 
higher than 2x. (p = 0.084).   
 
As stated above, values for V10m were also higher in 1x PJC as compared to PLA, 
however before further speculation on why this is, the secondary results from the inertial 
load power cycle test should be included in this explanation.  Vmax and T0 were both 
higher in 1x PJC, as compared to 2x PJC, with Ti being higher in 1x as compared to PLA 
as well.  The measurement for V10m is a value that indicates the individual’s ability to 
accelerate from over 10 meters from a standing position.  The initiation of power 
generation needed to accelerate in this measure is similar to the Ti that needs to be 
generated to produce Pmax.   It can therefore be reasonably postulated that higher values 
for V10m in the 1x PJC treatment are due to an increased ability to generate T0.  This may 
shed some light on why the 1x PJC treatment results in higher V10m values two hours after 
exercise.  It is not able to be determined in this current study why 1x PJC treatment 
displays higher values for Vmax and T0 compare to 2x PJC treatment.  It is possible that 
while 1x PJC protects the individual from extensive secondary damage, the 2x PJC may 
overprotect, hindering training adaptations.  
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In conclusion, 1x and 2x PJC supplementation were effective in eliciting higher values of 
isometric EF and KE strength, compared to PLA, throughout the 96-hours following 
eccentric exercise.  Although PJC supplementation does not affect soreness, once per day 
supplementation of PJC is equally effective as twice per day for recovery of isometric 




APPENDIX A - FIGURES 
Figure Legends 
Figure 1:  Testing Schedule 
Figure 2:  Visual Analog Scale (VAS) 
Figure 3:  Muscle soreness at complete elbow extension reported on a visual analog scale 
from 0 to 10.  Treatments were once-daily (1x) or twice daily (2x) pomegranate juice 
concentrate or placebo (PLA).  Values are reported as mean ± SEM.  
Figure 4:  Muscle soreness during unloaded elbow flexion reported on a visual analog 
scale from 0 to 10.  Treatments were once-daily (1x) or twice daily (2x) pomegranate 
juice concentrate or placebo (PLA).  Values are reported as mean ± SEM.  
Figure 5:  Muscle soreness during unloaded squat reported on a visual analog scale from 
0 to 10.  Treatments were once-daily (1x) or twice daily (2x) pomegranate juice 
concentrate or placebo (PLA).  Values are reported as mean ± SEM.  
Figure 6:  Muscle soreness at complete knee extension reported on a visual analog scale 
from 0 to 10.  Treatments were once-daily (1x) or twice daily (2x) pomegranate juice 
concentrate or placebo (PLA). * 1x significantly higher than PLA, overall treatment 
effect (p < 0.05).  Values are reported as mean ± SEM. 
Figure 7:  Isometric knee extensor (KE) strength expressed as a percent of pre-exercise 
values.  Treatments were once-daily (1x) or twice daily (2x) pomegranate juice 
concentrate or placebo (PLA).  * 1x significantly higher than PLA, overall treatment 
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effect (p < 0.05).  † 2x significantly higher than PLA, overall treatment effect (p < 0.05).  
Values are reported as mean ± SEM.   
Figure 8:  Isometric elbow flexor (EF) strength expressed as a percent of pre-exercise 
values.  Treatments were once-daily (1x) or twice daily (2x) pomegranate juice 
concentrate or placebo (PLA).  * 1x significantly higher than PLA, overall treatment 
effect (p < 0.05).  † 2x significantly higher than PLA, overall treatment effect (p < 0.05).  
Values are reported as mean ± SEM.   
Figure 9:  Inertial load maximal cycling power (Pmax) expressed as a percent of pre-
exercise values.  Treatments were once-daily (1x) or twice daily (2x) pomegranate juice 
concentrate or placebo (PLA).  Values are reported as mean ± SEM.   
Figure 10:  Inertial load maximal instantaneous power (IPmax) expressed as a percent of 
pre-exercise values.  Treatments were once-daily (1x) or twice daily (2x) pomegranate 
juice concentrate or placebo (PLA).  Values are reported as mean ± SEM.   
Figure 11:  Inertial load maximal velocity (Vmax) expressed as a percent of pre-exercise 
values.  Treatments were once-daily (1x) or twice daily (2x) pomegranate juice 
concentrate or placebo (PLA).  ‡ 1x significantly higher than 2x, overall treatment effect 
(p < 0.05).  Values are reported as mean ± SEM.   
Figure 12:  Inertial load maximal torque (Tmax) expressed as a percent of pre-exercise 
values.  Treatments were once-daily (1x) or twice daily (2x) pomegranate juice 
concentrate or placebo (PLA).  Values are reported as mean ± SEM.   
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Figure 13:  Inertial load torque at 0˚ (T0) expressed as a percent of pre-exercise values.  
Treatments were once-daily (1x) or twice daily (2x) pomegranate juice concentrate or 
placebo (PLA).  ‡ 1x significantly higher than 2x, overall treatment effect (p < 0.05).  * 
1x significantly higher than PLA, overall treatment effect (p < 0.05).  Values are reported 
as mean ± SEM.   
Figure 14:  Vertical jump height (VJheight ) expressed as a percent of pre-exercise values.  
Treatments were once-daily (1x) or twice daily (2x) pomegranate juice concentrate or 
placebo (PLA).  * 1x significantly higher than PLA, overall treatment effect (p < 0.05).  
Values are reported as mean ± SEM.   
Figure 15:  10-meter sprint velocity (V10m) expressed as a percent of pre-exercise values.  
Treatments were once-daily (1x) or twice daily (2x) pomegranate juice concentrate or 
placebo (PLA).  * 1x significantly higher than PLA, overall treatment effect (p < 0.05).  





Figure 1 – Eight Day Testing Period 
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S S S S 
Twice Daily Supplementation (1x, 2x, or PLA) 
S – Soreness and Performance Measurements 
EE – Eccentric Exercise 
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APPENDIX B – RAW DATA 
Elbow Extension Soreness 
Elbow Flexion Soreness 
Unloaded Squat Soreness 
Knee Extension Soreness 
Isometric Knee Extension Strength 
 Isometric Elbow Flexion Strength 
 Inertial Load Maximal Cycling Power 
 Maximal Instantaneous Power 
 Maximal Velocity 
 Maximal Torque 
 Torque at 0° 
Vertical Jump Height 
 10-Meter Sprint Velocity 
  
 57 
Elbow Extension Soreness   
       
              
1x PRE 2 h 24 h  48 h  72 h 96 h 
3 1.0 2.0 2.0 4.0 1.0 1.0 
9 0.0 1.0 4.0 4.0 3.0 2.0 
11 0.0 1.0 1.0 0.0 0.0 0.0 
13 0.0 2.0 4.0 5.0 6.0 4.0 
17 2.0 2.0 4.0 3.0 2.0 2.0 
20 0.0 3.0 5.0 3.0 2.0 0.0 
26 0.0 0.0 4.0 5.0 4.0 1.0 
29 0.0 0.0 1.0 0.0 0.0 0.0 
32 0.0 4.0 5.0 6.0 4.0 3.0 
35 1.0 1.0 2.0 2.0 1.0 0.0 
38 0.0 2.0 3.0 3.0 2.0 0.0 
41 0.0 5.0 6.0 6.0 7.0 6.0 
44 0.0 4.0 6.0 6.0 5.0 4.0 
48 0.0 3.0 6.0 5.0 4.0 3.0 
49 0.0 0.0 2.0 3.0 3.0 1.0 
Mean 0.3 2.0 3.7 3.7 2.9 1.8 
SD 0.6 1.6 1.8 2.0 2.1 1.9 
       
       
       
              
2x PRE 2 h 24 h  48 h  72 h 96 h 
4 0.0 2.0 4.0 4.0 1.0 1.0 
6 0.0 2.0 3.0 4.0 3.0 2.0 
8 0.0 1.0 4.0 3.0 1.0 0.0 
10 0.0 4.0 5.0 4.0 2.0 0.0 
14 0.0 2.0 7.0 5.0 5.0 1.0 
16 0.0 0.0 3.0 4.0 4.0 2.0 
19 0.0 5.0 6.0 5.0 3.0 1.0 
25 0.0 3.0 8.0 4.0 3.0 0.0 
28 0.0 1.0 2.0 3.0 2.0 0.0 
31 0.0 0.0 3.0 1.0 0.0 0.0 
34 0.0 0.0 1.0 1.0 2.0 0.0 
40 0.0 8.0 4.0 5.0 3.0 0.0 
43 0.0 2.0 5.0 5.0 2.0 2.0 
46 0.0 0.0 1.0 2.0 2.0 2.0 
47 0.0 1.0 2.0 2.0 0.0 0.0 
Mean 0.0 2.1 3.9 3.5 2.2 0.7 




Elbow Extension Soreness   
       
              
PLA PRE 2 h 24 h  48 h  72 h 96 h 
1 0.0 0.0 0.5 3.0 3.5 3.0 
2 0.0 0.0 5.0 4.0 3.0 2.0 
5 0.0 2.0 4.0 5.0 4.0 2.0 
7 0.5 2.5 6.0 5.0 3.5 3.0 
12 0.0 2.0 2.0 1.0 0.0 0.0 
18 0.0 1.0 3.0 4.0 2.0 1.0 
21 0.0 4.0 4.0 6.0 2.0 0.0 
24 0.0 2.0 2.0 2.0 5.0 3.0 
30 0.0 0.0 5.0 3.0 1.0 0.0 
33 0.0 5.0 6.0 4.0 3.0 1.0 
36 0.0 0.0 1.0 2.0 2.0 1.0 
39 0.0 2.0 4.0 2.0 1.0 0.0 
42 0.0 0.0 3.0 3.0 1.0 0.0 
45 0.0 3.0 5.0 6.0 5.0 5.0 
50 0.0 3.0 2.0 2.0 1.0 1.0 
Mean 0.0 1.8 3.5 3.5 2.5 1.5 




Elbow Flexion Soreness   
       
              
1x PRE 2 h 24 h 48 h 72 h 96 h 
3 1.0 2.0 2.0 4.0 1.0 1.0 
9 0.0 2.0 3.0 3.0 2.0 2.0 
11 0.0 0.0 2.0 0.0 0.0 0.0 
13 0.0 0.0 3.0 5.0 4.0 3.0 
17 2.0 2.0 5.0 4.0 2.0 3.0 
20 0.0 6.0 8.0 6.0 3.0 1.0 
26 0.0 0.0 2.0 6.0 4.0 2.0 
29 0.0 0.0 4.0 5.0 2.0 0.0 
32 0.0 4.0 4.0 5.0 3.0 2.0 
35 1.0 0.0 1.0 3.0 1.0 1.0 
38 0.0 6.0 5.0 4.0 2.0 1.0 
41 0.0 5.0 5.0 5.0 6.0 6.0 
44 0.0 4.0 7.0 7.0 6.0 4.0 
48 0.0 4.0 7.0 2.0 4.0 3.0 
49 0.0 2.0 2.0 2.0 1.0 0.0 
Mean 0.3 2.5 4.0 4.1 2.7 1.9 
SD 0.6 2.2 2.1 1.8 1.8 1.7 
       
       
       
              
2x PRE 2 h 24 h  48 h  72 h 96 h 
4 0.0 2.0 5.0 4.0 1.0 0.0 
6 0.0 2.0 2.0 2.0 2.0 1.0 
8 0.0 1.0 5.0 4.0 2.0 0.0 
10 0.0 5.0 5.0 5.0 2.0 1.0 
14 1.0 2.0 7.0 3.0 1.0 0.0 
16 0.0 2.0 3.0 4.0 4.0 2.0 
19 0.0 5.0 6.0 5.0 2.0 1.0 
25 0.0 3.0 8.0 5.0 3.0 2.0 
28 0.0 1.0 1.0 2.0 2.0 0.0 
31 1.0 3.0 5.0 3.0 2.0 1.0 
34 0.0 2.0 1.0 1.0 2.0 0.0 
40 0.0 8.0 8.0 6.0 3.0 0.0 
43 0.0 3.0 6.0 6.0 3.0 2.0 
46 0.0 1.0 4.0 4.0 3.0 2.0 
47 0.0 1.0 4.0 4.0 1.0 1.0 
Mean 0.1 2.7 4.7 3.9 2.2 0.9 




Elbow Flexion Soreness   
       
              
PLA PRE 2 h 24 h  48 h  72 h 96 h 
1 0.0 5.0 3.5 5.0 3.5 3.0 
2 0.0 5.0 4.0 5.0 3.0 1.0 
5 0.0 2.0 4.0 5.0 3.0 1.0 
7 0.0 2.0 6.5 5.0 4.0 3.0 
12 0.0 2.0 2.0 1.0 0.0 0.0 
18 0.0 1.0 3.0 4.0 3.0 2.0 
21 0.0 5.0 3.0 3.0 2.0 2.0 
24 0.0 3.0 3.0 4.0 4.0 4.0 
30 0.0 1.0 5.0 3.0 1.0 0.0 
33 0.0 5.0 6.0 4.0 3.0 0.0 
36 0.0 0.0 1.0 2.0 1.0 0.0 
39 0.0 4.0 5.0 4.0 1.0 1.0 
42 0.0 0.0 2.0 2.0 1.0 0.0 
45 0.0 3.0 6.0 6.0 5.0 5.0 
50 0.0 6.0 4.0 2.0 2.0 1.0 
Mean 0.0 2.9 3.9 3.7 2.4 1.5 




Unloaded Squat Soreness   
       
              
1x PRE 2 h 24 h  48 h  72 h 96 h 
3 1.0 5.0 3.0 6.0 3.0 2.0 
9 1.0 2.0 1.0 2.0 0.0 1.0 
11 0.0 0.0 0.0 0.0 0.0 0.0 
13 0.0 1.0 3.0 2.0 1.0 0.0 
17 3.0 4.0 4.0 4.0 3.0 4.0 
20 0.0 3.0 6.0 3.0 0.0 0.0 
26 0.0 1.0 2.0 3.0 0.0 0.0 
29 0.0 4.0 4.0 1.0 1.0 0.0 
32 0.0 3.0 3.0 5.0 3.0 2.0 
35 0.0 2.0 3.0 4.0 2.0 1.0 
38 1.0 4.0 4.0 2.0 1.0 0.0 
41 0.0 2.0 3.0 1.0 0.0 0.0 
44 3.0 5.0 6.0 6.0 5.0 5.0 
48 0.0 2.0 4.0 2.0 1.0 1.0 
49 0.0 2.0 3.0 1.0 1.0 1.0 
Mean 0.6 2.7 3.3 2.8 1.4 1.1 
SD 1.1 1.5 1.6 1.9 1.5 1.6 
       
       
       
              
2x PRE 2 h 24 h  48 h  72 h 96 h 
4 0.0 4.0 6.0 5.0 2.0 1.0 
6 0.0 2.0 2.0 2.0 2.0 1.0 
8 0.0 0.0 0.0 0.0 0.0 0.0 
10 0.0 2.0 4.0 3.0 0.0 0.0 
14 1.0 3.0 5.0 1.0 1.0 0.0 
16 1.0 4.0 4.0 5.0 5.0 3.0 
19 1.0 3.0 5.0 2.0 1.0 1.0 
25 0.0 5.0 3.0 1.0 0.0 0.0 
28 0.0 1.0 2.0 1.0 0.0 0.0 
31 2.0 4.0 4.0 3.0 3.0 2.0 
34 0.0 2.0 2.0 3.0 1.0 1.0 
40 0.0 5.0 5.0 3.0 3.0 0.0 
43 0.0 4.0 5.0 4.0 2.0 1.0 
46 0.0 2.0 3.0 4.0 0.0 0.0 
47 1.0 2.0 5.0 3.0 1.0 1.0 
Mean 0.4 2.9 3.7 2.7 1.4 0.7 




Unloaded Squat Soreness   
       
              
PLA PRE 2 h 24 h  48 h  72 h 96 h 
1 0.0 2.0 0.5 0.0 0.0 0.0 
2 0.0 4.0 2.0 2.0 1.0 0.0 
5 0.0 2.0 2.0 4.0 2.0 0.0 
7 0.5 2.5 7.0 6.5 6.5 4.5 
12 0.0 1.0 3.0 1.0 0.0 0.0 
18 0.0 1.0 2.0 2.0 2.0 1.0 
21 0.0 3.0 5.0 4.0 2.0 0.0 
24 0.0 1.0 1.0 2.0 2.0 1.0 
30 0.0 1.0 5.0 2.0 0.0 0.0 
33 2.0 6.0 5.0 4.0 2.0 1.0 
36 0.0 1.0 4.0 3.0 0.0 0.0 
39 0.0 2.0 4.0 2.0 1.0 0.0 
42 0.0 1.0 8.0 9.0 7.0 1.0 
45 0.0 3.0 3.0 3.0 2.0 0.0 
50 0.0 2.0 3.0 2.0 3.0 2.0 
Mean 0.2 2.2 3.6 3.1 2.0 0.7 




Knee Extension Soreness   
       
              
1x PRE 2 h 24 h  48 h  72 h 96 h 
3 1.0 3.0 2.0 4.0 4.0 1.0 
9 1.0 3.0 2.0 3.0 2.0 2.0 
11 1.0 1.0 0.0 0.0 1.0 1.0 
13 0.0 1.0 2.0 1.0 1.0 1.0 
17 4.0 4.0 5.0 5.0 4.0 3.0 
20 1.0 3.0 5.0 2.0 1.0 0.0 
26 0.0 0.0 4.0 4.0 2.0 0.0 
29 0.0 3.0 1.0 1.0 1.0 0.0 
32 0.0 2.0 4.0 5.0 2.0 0.0 
35 0.0 1.0 1.0 2.0 1.0 1.0 
38 0.0 3.0 3.0 0.0 1.0 0.0 
41 0.0 1.0 2.0 1.0 0.0 0.0 
44 3.0 4.0 5.0 5.0 3.0 3.0 
48 0.0 1.0 4.0 2.0 1.0 1.0 
49 0.0 3.0 4.0 4.0 4.0 2.0 
Mean 0.7 2.2 2.9 2.6 1.9 1.0 
SD 1.2 1.3 1.6 1.8 1.3 1.1 
       
       
       
              
2x PRE 2 h 24 h  48 h  72 h 96 h 
4 0.0 5.0 6.0 6.0 2.0 1.0 
6 0.0 2.0 3.0 3.0 1.0 1.0 
8 0.0 0.0 0.0 0.0 0.0 0.0 
10 0.0 2.0 2.0 2.0 0.0 0.0 
14 0.0 2.0 2.0 0.0 1.0 0.0 
16 1.0 3.0 4.0 4.0 4.0 2.0 
19 1.0 3.0 4.0 2.0 2.0 1.0 
25 0.0 1.0 1.0 0.0 0.0 0.0 
28 0.0 1.0 1.0 3.0 2.0 0.0 
31 1.0 4.0 3.0 3.0 3.0 2.0 
34 0.0 0.0 0.0 0.0 0.0 0.0 
40 0.0 4.0 5.0 2.0 2.0 0.0 
43 0.0 3.0 6.0 5.0 3.0 2.0 
46 0.0 1.0 0.0 0.0 0.0 0.0 
47 0.0 1.0 3.0 2.0 0.0 1.0 
Mean 0.2 2.1 2.7 2.1 1.3 0.7 




Knee Extension Soreness   
       
              
PLA PRE 2 h 24 h  48 h  72 h 96 h 
1 0.0 1.5 0.0 0.0 0.0 0.0 
2 0.0 0.0 3.0 2.0 1.0 0.0 
5 0.0 1.0 1.0 4.0 1.0 0.0 
7 0.5 3.0 5.0 4.5 4.0 2.5 
12 0.0 1.0 2.0 1.0 0.0 0.0 
18 0.0 1.0 2.0 2.0 2.0 1.0 
21 0.0 0.0 0.0 1.0 0.0 0.0 
24 0.0 1.0 0.0 1.0 2.0 1.0 
30 0.0 2.0 2.0 2.0 1.0 0.0 
33 2.0 7.0 5.0 3.0 1.0 1.0 
36 0.0 0.0 0.0 2.0 0.0 0.0 
39 0.0 2.0 4.0 2.0 1.0 0.0 
42 0.0 1.0 5.0 7.0 3.0 0.0 
45 0.0 3.0 3.0 2.0 1.0 0.0 
50 0.0 0.0 3.0 2.0 3.0 1.0 
Mean 0.2 1.6 2.3 2.4 1.3 0.4 




Isometric Knee Extension Strength   
       
              
1x PRE 2 h 24 h  48 h  72 h 96 h 
3 100.0% 92.4% 104.0% 101.8% 104.0% 106.7% 
9 100.0% 87.5% 90.4% 92.9% 88.4% 92.0% 
11 100.0% 86.3% 94.6% 94.6% 97.5% 90.3% 
13 100.0% 86.3% 94.5% 96.9% 92.9% 96.5% 
17 100.0% 82.9% 99.4% 86.2% 108.8% 84.0% 
20 100.0% 93.0% 91.3% 99.0% 89.6% 98.3% 
26 100.0% 100.9% 95.4% 91.2% 91.2% 102.7% 
29 100.0% 94.9% 94.9% 94.6% 95.4% 94.0% 
32 100.0% 69.1% 75.2% 82.4% 88.2% 94.2% 
35 100.0% 83.8% 79.8% 86.4% 85.1% 90.4% 
38 100.0% 102.6% 101.8% 102.6% 92.0% 97.4% 
41 100.0% 80.5% 85.1% 99.1% 95.4% 92.4% 
44 100.0% 99.6% 103.1% 102.7% 108.5% 111.2% 
48 100.0% 80.5% 91.3% 95.7% 97.1% 96.0% 
49 100.0% 93.3% 94.8% 101.1% 100.0% 105.6% 
Mean 100.0% 88.9% 93.0% 95.1% 95.6% 96.8% 
SD 0.0% 9.0% 8.1% 6.4% 7.2% 7.2% 
       
       
       
              
2x PRE 2 h 24 h  48 h  72 h 96 h 
4 100.0% 84.3% 89.5% 74.5% 82.4% 88.2% 
6 100.0% 75.7% 86.1% 84.8% 89.6% 101.3% 
8 100.0% 91.8% 104.1% 92.5% 100.4% 102.2% 
10 100.0% 90.7% 96.1% 103.9% 104.3% 103.6% 
14 100.0% 93.6% 94.1% 95.0% 90.4% 91.8% 
16 100.0% 90.4% 98.4% 97.3% 98.4% 101.6% 
19 100.0% 85.4% 89.6% 91.5% 88.9% 85.8% 
25 100.0% 95.8% 98.6% 93.5% 85.7% 88.2% 
28 100.0% 93.3% 95.8% 99.3% 95.8% 91.9% 
31 100.0% 90.8% 90.5% 91.9% 96.0% 91.9% 
34 100.0% 91.4% 112.1% 98.0% 93.9% 104.0% 
40 100.0% 80.1% 79.7% 91.1% 81.9% 86.1% 
43 100.0% 81.1% 76.6% 76.6% 87.1% 94.5% 
46 100.0% 87.4% 87.4% 92.0% 95.3% 97.8% 
47 100.0% 79.0% 77.7% 94.2% 95.5% 90.3% 
Mean 100.0% 87.4% 91.7% 91.7% 92.4% 94.6% 




Isometric Knee Extension Strength   
       
              
PLA PRE 2 h 24 h  48 h  72 h 96 h 
1 100.0% 93.1% 96.9% 78.9% 94.7% 94.0% 
2 100.0% 85.7% 79.9% 88.1% 84.5% 93.3% 
5 100.0% 85.8% 87.1% 90.9% 94.7% 91.5% 
7 100.0% 77.3% 78.9% 88.4% 80.2% 95.0% 
12 100.0% 89.1% 90.3% 99.1% 91.1% 91.1% 
18 100.0% 98.1% 82.7% 92.9% 72.9% 82.0% 
21 100.0% 91.2% 84.8% 80.6% 89.1% 96.4% 
24 100.0% 84.5% 104.0% 101.1% 90.6% 84.5% 
30 100.0% 86.0% 73.7% 82.6% 82.9% 80.1% 
33 100.0% 64.2% 72.2% 82.5% 84.6% 79.0% 
36 100.0% 79.8% 56.9% 86.7% 71.1% 67.0% 
39 100.0% 91.6% 89.4% 97.7% 93.2% 88.6% 
42 100.0% 75.2% 90.6% 84.6% 82.3% 81.1% 
45 100.0% 101.4% 96.4% 101.1% 101.1% 97.8% 
50 100.0% 96.7% 91.4% 99.5% 86.2% 82.9% 
Mean 100.0% 86.7% 85.0% 90.3% 86.6% 87.0% 




Isometric Elbow Flexion Strength   
       
              
1x PRE 2 h 24 h  48 h  72 h 96 h 
3 100.0% 76.9% 87.9% 94.5% 98.9% 98.9% 
9 100.0% 80.4% 88.2% 92.2% 88.2% 96.1% 
11 100.0% 69.4% 67.7% 74.2% 82.3% 91.9% 
13 100.0% 70.0% 70.0% 85.0% 93.3% 90.0% 
17 100.0% 85.4% 90.2% 102.4% 112.2% 119.5% 
20 100.0% 73.8% 72.3% 81.5% 89.2% 87.7% 
26 100.0% 86.2% 90.8% 89.7% 85.1% 92.0% 
29 100.0% 72.0% 76.0% 78.7% 86.7% 89.3% 
32 100.0% 57.8% 70.3% 76.6% 93.8% 98.4% 
35 100.0% 81.5% 80.0% 86.2% 90.8% 89.2% 
38 100.0% 62.7% 85.1% 76.1% 92.5% 88.1% 
41 100.0% 62.2% 55.4% 56.8% 64.9% 77.0% 
44 100.0% 92.4% 101.3% 94.9% 107.6% 112.7% 
48 100.0% 56.7% 62.5% 68.3% 71.2% 76.0% 
49 100.0% 74.4% 75.6% 88.5% 89.7% 94.9% 
Mean 100.0% 73.5% 78.2% 83.0% 89.8% 93.4% 
SD 0.0% 10.7% 12.3% 11.7% 11.9% 11.3% 
       
       
       
              
2x PRE 2 h 24 h  48 h  72 h 96 h 
4 100.0% 87.8% 77.6% 87.8% 77.6% 95.9% 
6 100.0% 73.1% 77.6% 73.1% 88.1% 80.6% 
8 100.0% n.d. 78.3% 89.1% 93.5% 97.8% 
10 100.0% 69.9% 82.2% 91.8% 112.3% 104.1% 
14 100.0% 82.4% 88.2% 90.2% 96.1% 102.0% 
16 100.0% 83.1% 86.4% 86.4% 86.4% 96.6% 
19 100.0% 75.7% 81.1% 85.6% 87.4% 87.4% 
25 100.0% 77.8% 70.4% 79.0% 90.1% 91.4% 
28 100.0% 66.2% 70.3% 66.2% 77.0% 78.4% 
31 100.0% 66.7% 94.7% 98.2% 103.5% 103.5% 
34 100.0% 79.2% 79.2% 81.1% 84.9% 90.6% 
40 100.0% 90.8% 98.9% 97.7% 103.4% 97.7% 
43 100.0% 66.7% 60.3% 76.2% 95.2% 100.0% 
46 100.0% 70.2% 73.8% 77.4% 83.3% 92.9% 
47 100.0% 84.9% 86.0% 90.3% 93.5% 91.4% 
Mean 100.0% 76.7% 80.3% 84.7% 91.5% 94.0% 




Isometric Elbow Flexion Strength   
       
              
PLA PRE 2 h 24 h  48 h  72 h 96 h 
1 100.0% 68.4% 60.8% 54.4% 65.8% 68.4% 
2 100.0% 74.5% 80.9% 80.9% 85.1% 91.5% 
5 100.0% 80.0% 84.0% 82.7% 93.3% 84.0% 
7 100.0% 78.3% 80.4% 82.6% 87.0% 91.3% 
12 100.0% 69.5% 69.5% 78.0% 75.6% 76.8% 
18 100.0% 87.3% 88.6% 93.7% 88.6% 93.7% 
21 100.0% 72.1% 67.3% 76.0% 76.9% 82.7% 
24 100.0% 67.2% 75.0% 79.7% 76.6% 81.3% 
30 100.0% 60.0% 51.3% 77.5% 77.5% 88.8% 
33 100.0% 78.8% 67.5% 75.0% 71.3% 75.0% 
36 100.0% 77.6% 81.0% 84.5% 84.5% 91.4% 
39 100.0% 85.2% 83.3% 87.0% 90.7% 92.6% 
42 100.0% 65.3% 71.4% 73.5% 77.6% 79.6% 
45 100.0% 75.0% 62.0% 73.1% 85.2% 83.3% 
50 100.0% 84.5% 72.4% 91.4% 81.0% 74.1% 
Mean 100.0% 74.9% 73.0% 79.3% 81.1% 83.6% 




Inertial Load Maximal Cycling Power   
       
              
1x PRE 2 h 24 h  48 h  72 h 96 h 
3 100.0% 99.0% 101.7% 94.5% 103.3% 104.7% 
9 100.0% 104.0% 97.6% 99.2% 96.9% 99.3% 
11 100.0% 87.4% 92.8% 91.4% 89.7% 97.6% 
13 100.0% 93.5% 100.2% 101.4% 96.7% 94.8% 
17 100.0% 100.0% 95.9% 105.1% 111.0% 98.4% 
20 100.0% 88.6% 81.9% 79.2% 85.1% 87.1% 
26 100.0% 98.0% 101.6% 99.3% 92.5% 85.9% 
29 100.0% 94.0% 100.0% 98.5% 104.4% 104.2% 
32 100.0% 90.4% 96.8% 89.7% 92.8% 90.9% 
35 100.0% 89.8% 98.2% 89.2% 98.2% 93.1% 
38 100.0% 93.8% 96.2% 98.5% 101.5% 106.0% 
41 100.0% 98.7% 96.6% 100.1% 100.1% 98.9% 
44 100.0% 98.1% 95.7% 97.3% 97.1% 92.5% 
48 100.0% 90.8% 90.4% 95.4% 97.4% 95.6% 
49 100.0% 108.7% 92.6% 89.1% 101.2% 103.4% 
Mean 100.0% 95.6% 95.9% 95.2% 97.9% 96.8% 
SD 0.0% 6.0% 5.0% 6.5% 6.3% 6.2% 
       
       
       
              
2x PRE 2 h 24 h  48 h  72 h 96 h 
4 100.0% 94.4% 96.8% 100.0% 98.4% 97.4% 
6 100.0% 86.3% 83.1% 91.9% 91.4% 98.6% 
8 100.0% 97.2% 100.7% 100.4% 101.5% 99.9% 
10 100.0% 93.4% 98.4% 104.1% 97.5% 98.6% 
14 100.0% 101.5% 97.1% 93.2% 96.6% 91.1% 
16 100.0% 97.7% 101.9% 98.8% 98.6% 94.6% 
19 100.0% 90.9% 98.4% 98.6% 95.5% 101.9% 
25 100.0% 88.6% 85.6% 91.9% 91.0% 92.9% 
28 100.0% 98.3% 97.9% 101.3% 101.9% 99.6% 
31 100.0% 95.0% 94.4% 95.0% 94.3% 90.2% 
34 100.0% 95.8% 99.3% 103.1% 100.5% 97.3% 
40 100.0% 94.8% 94.8% 105.2% 94.8% 97.0% 
43 100.0% 86.7% 67.7% 84.0% 88.7% 87.7% 
46 100.0% 89.3% 96.1% 95.7% 92.3% 94.6% 
47 100.0% 89.9% 98.4% 98.8% 103.5% 104.7% 
Mean 100.0% 93.3% 94.0% 97.5% 96.4% 96.4% 




Inertial Load Maximal Cycling Power   
       
              
PLA PRE 2 h 24 h  48 h  72 h 96 h 
1 100.0% 97.5% 95.5% 94.1% 102.5% 99.3% 
2 100.0% 90.1% 96.6% 90.8% 95.9% 92.5% 
5 100.0% 86.4% 98.1% 94.9% 94.0% 92.2% 
7 100.0% 99.2% 93.7% 102.2% 99.6% 102.6% 
12 100.0% 90.3% 95.7% 99.4% 98.0% 99.7% 
18 100.0% 94.8% 91.0% 91.9% 89.6% 92.7% 
21 100.0% 91.4% 91.8% 87.9% 94.3% 101.2% 
24 100.0% 95.0% 93.8% 105.3% 90.8% 94.2% 
30 100.0% 96.3% 93.8% 98.2% 103.0% 102.9% 
33 100.0% 90.0% 87.8% 100.2% 101.3% 89.5% 
36 100.0% 90.7% 86.4% 94.0% 97.9% 95.1% 
39 100.0% 93.7% 95.0% 96.1% 94.6% 95.1% 
42 100.0% 84.5% 98.1% 93.0% 96.3% 95.5% 
45 100.0% 96.8% 95.9% 93.4% 93.1% 88.5% 
50 100.0% 94.1% 86.3% 89.6% 86.9% 92.3% 
Mean 100.0% 92.7% 93.3% 95.4% 95.9% 95.6% 




Maximal Instantaneous Power  
      
            
1x PRE 24 h  48 h  72 h 96 h 
3 100.0% 101.7% 98.3% 104.1% 93.0% 
9 100.0% 87.6% 90.9% 93.3% 95.0% 
11 100.0% 92.9% 91.8% 90.7% 103.6% 
13 100.0% 97.5% 97.6% 94.4% 90.3% 
17 n.d. n.d. n.d. n.d. n.d. 
20 100.0% 88.9% 80.2% 84.8% 94.6% 
26 100.0% 106.8% 105.7% 96.0% 95.2% 
29 100.0% 94.2% 91.8% 96.2% 98.2% 
32 100.0% 94.4% 91.0% 94.8% 89.2% 
35 100.0% 103.9% 96.3% 106.2% 105.5% 
38 100.0% 106.1% 92.5% 101.6% 97.0% 
41 100.0% 102.4% 104.2% 101.0% 109.3% 
44 100.0% 94.9% 99.8% 95.8% 92.5% 
48 100.0% 91.9% 88.2% 92.6% 90.8% 
49 n.d. n.d. n.d. n.d. n.d. 
Mean 100.0% 97.2% 94.5% 96.3% 96.5% 
SD 0.0% 6.4% 6.8% 5.8% 6.2% 
      
      
      
            
2x PRE 24 h  48 h  72 h 96 h 
4 100.0% 107.1% 107.6% 103.9% 105.2% 
6 100.0% 88.4% 84.5% 99.3% 104.0% 
8 100.0% 107.6% 103.5% 105.4% 104.5% 
10 100.0% 100.1% 101.4% 94.9% 102.3% 
14 n.d. n.d. n.d. n.d. n.d. 
16 100.0% 102.1% 100.1% 99.4% 91.4% 
19 100.0% 102.0% 102.5% 94.6% 104.1% 
25 100.0% 92.5% 103.1% 93.7% 98.3% 
28 100.0% 99.5% 109.0% 113.2% 113.8% 
31 100.0% 95.6% 96.6% 95.6% 90.9% 
34 100.0% 97.9% 100.7% 98.7% 95.8% 
40 100.0% 85.3% 92.6% 94.6% 89.1% 
43 100.0% 66.4% 75.9% 93.7% 90.5% 
46 100.0% 99.7% 96.0% 94.5% 93.4% 
47 100.0% 105.7% 101.4% 107.0% 106.1% 
Mean 100.0% 96.4% 98.2% 99.2% 99.2% 




Maximal Instantaneous Power  
      
            
PLA PRE 24 h  48 h  72 h 96 h 
1 100.0% 98.9% 96.6% 103.7% 104.5% 
2 100.0% 102.5% 91.3% 101.6% 95.0% 
5 100.0% 97.5% 97.3% 91.6% 93.0% 
7 n.d. n.d. n.d. n.d. n.d. 
12 100.0% 96.4% 98.2% 99.1% 103.1% 
18 100.0% 89.4% 89.8% 86.1% 92.6% 
21 100.0% 111.1% 95.3% 98.8% 105.4% 
24 100.0% 93.1% 98.4% 85.6% 92.9% 
30 100.0% 99.9% 106.7% 112.6% 110.5% 
33 100.0% 96.9% 103.3% 107.7% 105.9% 
36 100.0% 85.9% 95.5% 96.4% 98.1% 
39 100.0% 95.4% 94.5% 92.8% 92.6% 
42 100.0% 108.7% 103.1% 108.3% 99.6% 
45 100.0% 95.3% 95.0% 89.5% 85.2% 
50 n.d. n.d. n.d. n.d. n.d. 
Mean 100.0% 97.8% 97.3% 98.0% 98.3% 




Maximal Velocity  
      
            
1x PRE 24 h  48 h  72 h 96 h 
3 100.0% 100.0% 97.4% 104.4% 112.3% 
9 100.0% 119.8% 110.8% 109.9% 105.4% 
11 100.0% 92.2% 96.9% 95.3% 93.8% 
13 100.0% 109.5% 106.9% 112.9% 100.9% 
17 n.d. n.d. n.d. n.d. n.d. 
20 100.0% 105.2% 111.2% 115.7% 97.8% 
26 100.0% 101.7% 97.4% 106.8% 97.4% 
29 100.0% 104.9% 104.1% 109.8% 110.6% 
32 100.0% 96.8% 96.0% 87.2% 92.0% 
35 100.0% 93.8% 95.1% 89.6% 98.6% 
38 100.0% 88.2% 109.4% 98.4% 103.9% 
41 100.0% 96.5% 102.8% 99.3% 95.1% 
44 100.0% 102.9% 104.3% 95.0% 95.0% 
48 100.0% 90.9% 97.0% 100.8% 97.0% 
49 n.d. n.d. n.d. n.d. n.d. 
Mean 100.0% 100.2% 102.3% 101.9% 100.0% 
SD 0.0% 8.6% 6.0% 8.9% 6.3% 
      
      
      
            
2x PRE 24 h  48 h  72 h 96 h 
4 100.0% 91.7% 104.2% 98.3% 98.3% 
6 100.0% 86.6% 94.1% 89.9% 91.6% 
8 100.0% 95.3% 98.4% 104.7% 103.9% 
10 100.0% 102.4% 105.5% 95.3% 97.6% 
14 n.d. n.d. n.d. n.d. n.d. 
16 100.0% 85.6% 84.2% 81.3% 96.4% 
19 100.0% 97.1% 99.3% 97.1% 102.9% 
25 100.0% 92.9% 95.0% 98.6% 100.7% 
28 100.0% 99.2% 94.3% 100.0% 99.2% 
31 100.0% 99.2% 99.2% 99.2% 88.2% 
34 100.0% 108.0% 106.3% 95.5% 100.9% 
40 100.0% 104.3% 108.5% 100.0% 100.9% 
43 100.0% 93.2% 100.0% 106.0% 101.7% 
46 100.0% 95.6% 96.3% 95.6% 97.8% 
47 100.0% 98.3% 98.3% 100.8% 100.0% 
Mean 100.0% 96.4% 98.8% 97.3% 98.6% 




Maximal Velocity  
      
            
PLA PRE 24 h  48 h  72 h 96 h 
1 100.0% 96.6% 95.8% 97.5% 97.5% 
2 100.0% 96.7% 102.4% 107.3% 111.4% 
5 100.0% 106.7% 100.0% 109.0% 99.3% 
7 n.d. n.d. n.d. n.d. n.d. 
12 100.0% 108.2% 104.9% 104.1% 100.8% 
18 100.0% 100.0% 106.3% 114.3% 110.7% 
21 100.0% 96.1% 112.4% 112.4% 100.8% 
24 100.0% 100.9% 107.8% 106.9% 113.8% 
30 100.0% 92.9% 89.3% 87.1% 97.9% 
33 100.0% 82.0% 95.0% 103.6% 82.7% 
36 100.0% 102.3% 103.1% 106.9% 101.5% 
39 100.0% 102.3% 97.7% 106.1% 106.9% 
42 100.0% 88.0% 86.5% 88.7% 95.5% 
45 100.0% 100.7% 97.9% 102.1% 103.4% 
50 n.d. n.d. n.d. n.d. n.d. 
Mean 100.0% 98.0% 99.9% 103.5% 101.7% 




Maximal Torque  
      
            
1x PRE 24 h  48 h  72 h 96 h 
3 100.0% 101.3% 97.5% 98.7% 92.4% 
9 100.0% 76.8% 83.8% 82.8% 88.9% 
11 100.0% 101.4% 94.2% 94.2% 104.3% 
13 100.0% 92.0% 96.0% 85.3% 94.7% 
17 n.d. n.d. n.d. n.d. n.d. 
20 100.0% 82.2% 74.0% 76.7% 93.2% 
26 100.0% 101.0% 102.0% 87.9% 98.0% 
29 100.0% 96.4% 96.4% 95.2% 95.2% 
32 100.0% 98.8% 90.4% 103.6% 97.6% 
35 100.0% 104.6% 93.8% 109.2% 93.8% 
38 100.0% 117.9% 91.0% 103.0% 103.0% 
41 100.0% 101.2% 98.8% 102.4% 105.9% 
44 100.0% 93.5% 93.5% 103.3% 96.7% 
48 100.0% 98.7% 98.7% 97.5% 97.5% 
49 n.d. n.d. n.d. n.d. n.d. 
Mean 100.0% 97.4% 93.1% 95.4% 97.0% 
SD 0.0% 10.2% 7.3% 9.6% 4.9% 
      
      
      
            
2x PRE 24 h  48 h  72 h 96 h 
4 100.0% 105.9% 96.1% 99.0% 99.0% 
6 100.0% 96.3% 87.5% 102.5% 107.5% 
8 100.0% 104.2% 100.0% 97.2% 95.8% 
10 100.0% 96.2% 98.7% 103.8% 103.8% 
14 n.d. n.d. n.d. n.d. n.d. 
16 100.0% 119.6% 115.7% 121.6% 98.0% 
19 100.0% 101.1% 100.0% 101.1% 98.9% 
25 100.0% 92.9% 98.0% 92.9% 93.9% 
28 100.0% 98.7% 107.7% 101.3% 100.0% 
31 100.0% 96.1% 96.1% 94.7% 102.6% 
34 100.0% 92.4% 94.9% 105.1% 94.9% 
40 100.0% 90.1% 97.5% 93.8% 95.1% 
43 100.0% 71.9% 82.0% 82.0% 86.5% 
46 100.0% 99.0% 99.0% 96.0% 97.0% 
47 100.0% 100.0% 99.1% 101.9% 102.8% 
Mean 100.0% 97.5% 98.0% 99.5% 98.3% 




Maximal Torque  
      
            
PLA PRE 24 h  48 h  72 h 96 h 
1 100.0% 98.9% 97.8% 101.1% 102.2% 
2 100.0% 98.6% 87.1% 88.6% 82.9% 
5 100.0% 92.6% 94.9% 86.0% 93.4% 
7 n.d. n.d. n.d. n.d. n.d. 
12 100.0% 88.6% 94.3% 93.2% 98.9% 
18 100.0% 89.8% 86.4% 77.3% 84.1% 
21 100.0% 95.6% 78.0% 83.5% 101.1% 
24 100.0% 92.4% 96.2% 83.5% 81.0% 
30 100.0% 100.0% 107.5% 115.1% 103.2% 
33 100.0% 105.7% 104.3% 97.1% 108.6% 
36 100.0% 84.2% 90.8% 92.1% 94.7% 
39 100.0% 96.3% 97.5% 88.9% 88.9% 
42 100.0% 112.1% 109.1% 109.1% 103.0% 
45 100.0% 94.6% 96.8% 90.3% 86.0% 
50 n.d. n.d. n.d. n.d. n.d. 
Mean 100.0% 96.1% 95.4% 92.8% 94.5% 




Torque at 0°  
      
            
1x PRE 24 h  48 h  72 h 96 h 
3 100.0% 73.9% 83.0% 100.7% 71.2% 
9 100.0% 208.8% 166.2% 230.9% 247.1% 
11 100.0% 86.0% 92.6% 86.8% 90.4% 
13 100.0% 101.8% 121.1% 94.7% 110.5% 
17 n.d. n.d. n.d. n.d. n.d. 
20 100.0% 94.4% 95.4% 114.8% 116.7% 
26 100.0% 101.7% 74.4% 92.2% 79.4% 
29 100.0% 101.3% 82.6% 101.9% 92.3% 
32 100.0% 135.8% 151.6% 165.3% 160.0% 
35 100.0% 112.5% 108.7% 115.4% 110.6% 
38 100.0% 148.3% 94.8% 81.9% 78.4% 
41 100.0% 192.1% 180.3% 198.7% 142.1% 
44 100.0% 115.6% 122.5% 116.3% 113.1% 
48 100.0% 133.3% 137.7% 133.3% 143.0% 
49 n.d. n.d. n.d. n.d. n.d. 
Mean 100.0% 123.5% 116.2% 125.6% 119.6% 
SD 0.0% 40.0% 34.0% 45.7% 46.9% 
      
      
      
            
2x PRE 24 h  48 h  72 h 96 h 
4 100.0% 84.0% 62.9% 99.1% 92.5% 
6 100.0% 95.9% 100.7% 89.0% 115.9% 
8 100.0% 96.0% 98.0% 98.0% 97.3% 
10 100.0% 100.0% 103.4% 109.6% 97.9% 
14 n.d. n.d. n.d. n.d. n.d. 
16 100.0% 86.5% 82.7% 91.3% 80.8% 
19 100.0% 93.4% 98.9% 82.5% 86.3% 
25 100.0% 109.0% 94.9% 91.7% 115.4% 
28 100.0% 98.7% 102.6% 103.3% 86.3% 
31 100.0% 90.5% 108.0% 94.2% 75.9% 
34 100.0% 149.4% 113.8% 134.5% 173.6% 
40 100.0% 126.7% 132.2% 145.6% 144.4% 
43 100.0% 104.2% 147.9% 129.2% 106.3% 
46 100.0% 84.1% 61.0% 74.9% 92.3% 
47 100.0% 66.3% 55.8% 109.0% 58.3% 
Mean 100.0% 98.9% 97.3% 103.7% 101.7% 




Torque at 0°  
      
            
PLA PRE 24 h  48 h  72 h 96 h 
1 100.0% 100.0% 102.2% 98.3% 56.4% 
2 100.0% 91.7% 87.1% 91.7% 90.9% 
5 100.0% 88.1% 106.7% 88.1% 102.8% 
7 n.d. n.d. n.d. n.d. n.d. 
12 100.0% 90.1% 88.5% 97.4% 106.3% 
18 100.0% 65.2% 85.2% 81.3% 84.5% 
21 100.0% 100.0% 120.0% 91.8% 153.6% 
24 100.0% 150.0% 158.5% 140.4% 98.9% 
30 100.0% 117.6% 83.0% 113.1% 135.3% 
33 100.0% 72.0% 70.2% 63.7% 75.0% 
36 100.0% 91.3% 101.6% 102.4% 96.8% 
39 100.0% 95.2% 67.3% 80.3% 98.0% 
42 100.0% 99.2% 101.5% 97.0% 100.8% 
45 100.0% 157.8% 181.9% 168.7% 138.6% 
50 n.d. n.d. n.d. n.d. n.d. 
Mean 100.0% 101.4% 104.1% 101.1% 102.9% 
SD 0.0% 26.7% 33.1% 27.2% 26.5% 
  
 79 
Vertical Jump Height   
       
              
1x PRE 2 h 24 h  48 h  72 h 96 h 
3 100.0% 94.7% 100.0% 92.1% 97.4% 102.6% 
9 100.0% 97.1% 94.3% 97.1% 94.3% 97.1% 
11 100.0% 97.6% 100.0% 102.4% 104.9% 107.3% 
13 100.0% 96.7% 96.7% 100.0% 96.7% 100.0% 
17 100.0% 100.0% 93.9% 103.0% 103.0% 103.0% 
20 100.0% 97.3% 102.7% 102.7% 102.7% 100.0% 
26 100.0% 97.7% 97.7% 102.3% 104.5% 100.0% 
29 100.0% 102.5% 102.5% 102.5% 107.5% 107.5% 
32 100.0% 94.1% 97.1% 97.1% 100.0% 94.1% 
35 100.0% 95.1% 92.7% 92.7% 104.9% 95.1% 
38 100.0% 102.9% 100.0% 108.6% 108.6% 108.6% 
41 100.0% 100.0% 101.7% 103.4% 103.4% 105.2% 
44 100.0% 97.6% 100.0% 97.6% 95.1% 100.0% 
48 100.0% 89.7% 94.9% 94.9% 97.4% 100.0% 
49 100.0% 102.8% 100.0% 100.0% 105.6% 108.3% 
Mean 100.0% 97.7% 98.3% 99.8% 101.7% 101.9% 
SD 0.0% 3.6% 3.2% 4.5% 4.6% 4.7% 
       
       
       
              
2x PRE 2 h 24 h  48 h  72 h 96 h 
4 100.0% 93.9% 87.9% 100.0% 97.0% 97.0% 
6 100.0% 97.4% 102.6% 102.6% 117.9% 105.1% 
8 100.0% 97.0% 90.9% 93.9% 93.9% 97.0% 
10 100.0% 95.3% 100.0% 100.0% 95.3% 104.7% 
14 100.0% 92.1% 100.0% 97.4% 105.3% 102.6% 
16 100.0% 94.4% 94.4% 91.7% 86.1% 91.7% 
19 100.0% 95.8% 97.9% 102.1% 102.1% 102.1% 
25 100.0% 98.1% 98.1% 100.0% 103.8% 103.8% 
28 100.0% 100.0% 96.7% 100.0% 100.0% 103.3% 
31 100.0% 94.3% 94.3% 94.3% 100.0% 97.1% 
34 100.0% 96.7% 96.7% 100.0% 96.7% 106.7% 
40 100.0% 100.0% 102.3% 106.8% 109.1% 102.3% 
43 100.0% 97.1% 102.9% 97.1% 102.9% 102.9% 
46 100.0% 91.9% 102.7% 105.4% 110.8% 110.8% 
47 100.0% 100.0% 100.0% 102.6% 105.3% 102.6% 
Mean 100.0% 96.3% 97.8% 99.6% 101.7% 102.0% 




Vertical Jump Height   
       
              
PLA PRE 2 h 24 h  48 h  72 h 96 h 
1 100.0% 97.4% 100.0% 94.9% 97.4% 100.0% 
2 100.0% 93.0% 90.7% 93.0% 93.0% 93.0% 
5 100.0% 91.1% 97.8% 95.6% 100.0% 93.3% 
7 100.0% 100.0% 106.9% 106.9% 106.9% 106.9% 
12 100.0% 100.0% 97.1% 100.0% 100.0% 100.0% 
18 100.0% 100.0% 102.7% 100.0% 100.0% 100.0% 
21 100.0% 100.0% 98.0% 100.0% 102.0% 106.1% 
24 100.0% 97.6% 97.6% 95.1% 92.7% 95.1% 
30 100.0% 100.0% 102.0% 104.1% 104.1% 104.1% 
33 100.0% 103.2% 100.0% 96.8% 100.0% 96.8% 
36 100.0% 90.2% 95.1% 95.1% 97.6% 97.6% 
39 100.0% 95.8% 100.0% 100.0% 100.0% 100.0% 
42 100.0% 93.8% 90.6% 90.6% 96.9% 100.0% 
45 100.0% 100.0% 96.1% 96.1% 100.0% 98.0% 
50 100.0% 97.9% 91.7% 95.8% 91.7% 87.5% 
Mean 100.0% 97.3% 97.7% 97.6% 98.8% 98.6% 




10-Meter Sprint Velocity   
       
              
1x PRE 2 h 24 h  48 h  72 h 96 h 
3 100.0% 99.1% 98.7% 95.3% 98.7% 97.8% 
9 100.0% 98.9% 101.7% 98.9% 98.9% 101.7% 
11 100.0% 99.4% 93.3% 102.9% 105.9% 104.0% 
13 100.0% 102.2% 96.9% 102.2% 100.0% 102.2% 
17 100.0% 97.2% 97.2% 96.1% 98.3% 95.6% 
20 100.0% 98.9% 95.0% 97.2% 96.1% 95.0% 
26 100.0% 100.0% 97.6% 98.8% 100.0% 97.6% 
29 100.0% 98.8% 100.0% 98.2% 98.8% 98.8% 
32 100.0% 98.3% 96.6% 98.9% 98.9% n.d. 
35 n.d. n.d. n.d. n.d. n.d. n.d. 
38 100.0% 102.4% 100.0% 103.7% 105.6% 104.3% 
41 100.0% 101.9% 100.6% 100.0% 99.4% 101.9% 
44 100.0% 101.8% 99.4% 101.8% 104.4% 105.7% 
48 100.0% 96.0% 93.9% 93.9% 98.3% 97.7% 
49 100.0% 112.7% 104.3% 104.3% 107.1% 110.8% 
Mean 100.0% 100.6% 98.2% 99.4% 100.7% 101.0% 
SD 0.0% 4.0% 3.1% 3.2% 3.5% 4.5% 
       
       
       
              
2x PRE 2 h 24 h  48 h  72 h 96 h 
4 100.0% 94.4% 96.4% 97.9% 97.9% 98.4% 
6 100.0% 96.7% 100.0% 107.9% 104.7% 104.1% 
8 100.0% 96.1% 99.4% 95.1% 101.2% 101.8% 
10 100.0% 98.9% 103.6% 102.4% 101.2% 99.4% 
14 100.0% 98.4% 95.8% 97.9% 97.9% 98.4% 
16 100.0% 83.0% 103.9% 102.8% 101.1% 100.5% 
19 100.0% 95.7% 95.1% 94.5% 95.7% 94.5% 
25 n.d. n.d. n.d. n.d. n.d. n.d. 
28 100.0% 98.9% 99.4% 96.8% 97.8% 98.9% 
31 100.0% 101.7% 96.3% 101.1% 103.4% 101.1% 
34 n.d. n.d. n.d. n.d. n.d. n.d. 
40 n.d. n.d. n.d. n.d. n.d. n.d. 
43 100.0% 98.4% 95.4% 98.9% 99.5% 105.1% 
46 100.0% 99.4% 98.3% 98.8% 98.3% 100.0% 
47 n.d. n.d. n.d. n.d. n.d. n.d. 
Mean 100.0% 96.5% 98.5% 99.5% 99.9% 100.2% 




10-Meter Sprint Velocity   
       
       
PLA PRE 2 h 24 h  48 h  72 h 96 h 
1 100.0% 95.6% 96.9% 90.5% 95.2% 94.4% 
2 100.0% 83.0% 99.0% 97.6% 100.5% 100.0% 
5 n.d. n.d. n.d. n.d. n.d. n.d. 
7 100.0% 100.0% 97.9% 97.4% 95.8% 99.5% 
12 100.0% 96.1% 99.4% 103.0% 100.0% 106.1% 
18 100.0% 99.4% 98.4% 100.0% 102.3% 104.7% 
21 100.0% 95.9% 96.4% 92.1% 96.4% 97.6% 
24 n.d. n.d. n.d. n.d. n.d. n.d. 
30 100.0% 103.2% 98.8% 101.9% 99.4% 100.6% 
33 100.0% 99.4% 97.2% 96.6% 99.4% 96.1% 
36 n.d. n.d. n.d. n.d. n.d. n.d. 
39 100.0% 94.4% 96.6% 97.7% 98.8% 97.7% 
42 100.0% 94.5% 91.4% 92.4% 92.4% 93.4% 
45 100.0% 95.9% 99.4% 101.9% 101.9% 100.6% 
50 100.0% 98.8% 95.5% 96.1% 103.0% 101.8% 
Mean 100.0% 96.4% 97.2% 97.3% 98.8% 99.4% 
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